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Abstract
Many researchers have documented the trend of decreasing financial support from donors
for human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS)
responses in Ethiopia. Less information is available regarding the correlation between
trends of HIV prevalence and external funding and ways to address the impact that
funding scarcity could cause. The purpose of this study was to examine the trend of HIV
prevalence and donor funding levels, analyzing how the 2 are correlated, and
opportunities to improve responses. Using the proximate determinant framework, the
research questions examined the changes in HIV prevalence in Ethiopia during the past
10 years; the association between the trends of HIV prevalence, funding levels, and
services provided; and the effect of different characteristics on the trend of the
prevalence. A paired sample t-test, time series forecasting, Pearson correlation, chisquare test, and multiple regression were employed using a secondary data of sampled
1,067 people from the Demographic and Health Surveys and data from donors. Results
indicated that the change in prevalence was statistically significant (t [10] = 4.59, p =
.001), and correlated with the funding levels(r (10) = .635*, p = .027), a significant
relationship between funding level and type of services, χ2 (2, N = 1067) = 1425.7, p
<.001 and a significant regression equation to predict HIV prevalence (F (9, 1056) =
12.639, p < .001). The results from this study could be used to inform the Ministry of
Health of Ethiopia and HIV project implementers to plan for domestic sustainable
financing initiatives, invest based upon evidence-based HIV prevention strategies that
could most directly impact quality of life and guide future research.
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Section 1: Foundation of the Study and Literature Review
Substantial improvements have been documented regarding integrated Human
Immunodeficiency Virus (HIV)prevention and care services in many countries as huge
investments were targeting to provide integrated HIV prevention and treatment services
across the HIV care continuum (The Joint United Nations Programme on HIV/AIDS
[UNAIDS], 2017). However, because of decreases in funding, the possibility of relapse
of HIV pandemic is feared not to cause universal crisis and looming future progress
(United Nations General Assembly, 2016). One of the challenges is an ongoing funding
gap for HIV/AIDS programs. According to UNAIDS (2017), while $19 billion was
estimated to be accessible from domestic and international sources to address the problem
of low and middle income countries in the year 2016, this need for additional money will
increase to $26.2 billion by 2020 and the funding level to meet UNAIDS’s global targets
to end AIDS as a global public health threat will be gradually reduced by 9% by
2030(Stover, 2016).
According to PEPFAR (2013), though the total funding (bilateral and multilateral)
from the US government addresses the global HIV epidemic, since 2010, PEPFAR
funding levels have remained essentially flat or decreasing for some countries in Africa.
According to UNAIDS (2017), ending HIV/AIDS depend largely on the funding level
and ability of each country to provide HIV treatment to all who need it. Samji (2013) said
that defunding the HIV/AIDS program may cause catastrophic phenomena.
Poverty is a barrier for the achievement of HIV prevention (Shelton, 2005).
Poverty, underdevelopment, lack of choices for services, and the inability to determine
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one’s own destiny fuel the HIV epidemic (UNAIDS, 2001). According to Fenton (2004),
poverty leads people to high-risk behaviors and reducing poverty is the only viable longterm response to the epidemic.
In Africa, the prevalence of HIV correlates directly with wealth and there is a
strong positive correlation between household wealth and national income with HIV
infection prevalence across sub-Saharan Africa (PEPFAR, 2005).Since HIV’s discovery
in 1981, more than 25 million people have died of AIDS. Worldwide, 33 million people
are currently HIV positive, leading to a global adult prevalence of 0.8% (UNAIDS,
2008). Sub-Saharan Africa has the highest HIV prevalence at 5%, which makes up twothirds of the worldwide HIV burden (World Health Organization [WHO], 2016).
In Ethiopia two decades ago, there were 3 million HIV infected people, and an
estimated 280,000 people died of AIDS (UNAIDS, 2000). This was the largest infected
population worldwide after South Africa and India, and HIV/AIDS was one of the key
challenges for overall economic and human resource developments (DHS, 2011). Based
on a single point estimate, which is an estimate of unknown population parameter by
using sample data to calculate a single value (FMOH, 2007); currently in Ethiopia with a
population of 105 million, adult HIV prevalence is estimated to be 1.1%, and the
incidence rate is 0.29% (The Ethiopian Public Health Institute [EPHI], 2017). Prevalence
and incidence rates also significantly vary between geographical areas and gender
(Federal HIV/AIDS Prevention and Control Office [FHAPCO], 2008).The prevalence of
AIDS in the Gambella region is 6.6%, while in Addis Ababa it is 5%, and in the Southern
Nations, Nationalities and Peoples’ region it is 0.7%. Moreover, while urban prevalence
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in Ethiopia is 7.7%, rural prevalence is estimated to be 0.9%; in both areas, young
women remain at very high risk of HIV infection(Elsevier, B., 2016).The burden of HIV
in Ethiopia is decreasing because substantial advances have been made to increase access
to testing and treatment of HIV in many high-burden regions, prevent mother-to-child
transmission, integrate HIV services with Maternal and Child Health (MCH) services,
retention and Antiretroviral Therapy (ART) adherence, reduce stigma and discrimination,
increase social support, and mobilize communities (Kendall & Danel, 2014).
In this study, a 10-year trend analysis of HIV prevalence and funding levels from
donors for HIV/AIDS prevention and control activities in Ethiopia reviewed the link
between funding level and HIV treatment, care, and support services as well as how and
where domestic funds or national budgets are to be spent to address the epidemic, reduce
new infections, reduce AIDS related deaths, and eliminate stigma and discrimination
when funding from donors for HIV/AIDS program was declining. Consequently, the
potential positive social change implication of this study is health programmers, policy
makers, and researchers will be benefited because the finding of the study articulated
where the HIV epidemic is heading, how the trend of the epidemic correlated with the
funding levels allotted every year from donors for prevention, care, and support activities;
the change in HIV prevalence for different population subgroups, the relationship
between the type/number of services being given to control HIV/ADS and the funding
levels; and if the prevalence has a similar trend to all Socioeconomic and Demographic
Characteristics. After knowing the aforementioned changes, health programmers and
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policy makers can strategize the prevention responses and resources accordingly for
efficient and effective measures that enable to stop the spread and death of HIV/AIDS.
Problem Statement
In the prevention and control measures of HIV/AIDS, donor funding has a
significant role in developing countries (Kates, Lief, & Wexler, 2014). Donors in this
study are international grant making foundations providing funding resources and
technical assistance to help developing countries as they design and implement their
program strategies to fight HIV/AIDS. Sub-Saharan Africa has the greatest number of
recipient countries of any region and received the largest share of assistance from donors
(57% of global HIV/AIDS funding) and had the largest number of donors (Bendavid,
2012). Ethiopia accounts for 8% of funding from 27 donors in Sub-Saharan Africa and
the donor community has made remarkable support in the HIV/AIDS response (Kates,
Michaud, & Wexler, 2013).
However, currently, financial support from donors for HIV/AIDS response in
low-income countries including Ethiopia is being reduced (Garmaise, 2015). Specifically,
funding from PEPFAR, one of the successful anti-HIV/AIDS programs in Ethiopia, is
severely declining and likely to affect the availability of HIV drugs and other HIV/AIDSrelated assistance. Currently, because of this budget cut, many HIV prevention, care, and
support programs are being phased out or scaled back prematurely, which is a problem
that triggered this study. To address this problem and achieve the goal of ending HIV as a
public health threat by 2030, some priority strategies like intensifying coordinated HIV
prevention efforts, undertaking high impact targeted prevention activities, and targeted
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HIV counseling and testing are being taken (HAPCO, 2016); however, despite this,
shortage of resources is still a problem and affects the development programs of
HIV/AIDS, the community conversation initiatives on prevention strategies at the
community level, capacity development and policy support at national HIV/AIDS
councils support of decentralized HIV/AIDS responses at regional and district levels, the
support that civil society organizations (CSOs) had for HIV/AIDS responses, generation
of knowledge on HIV through research activities, mainstreaming the integration of
HIV/AIDS prevention activities into other programs’ activities, the provision of ART for
million infected people, support for HIV test laboratories, TB/HIV surveillance, support
for orphan and vulnerable children (OVC), infrastructure, and trainings (Kates et al.,
2013).
A possible factor contributing to these problems, phasing out of HIV programs
and scaled back scopes, is the decrement of global donor support as the result of
increasing funding demands such as humanitarian emergencies and refugee crises
combined with ongoing fiscal austerity in many countries (UNAIDS & Henry, 2016). For
instance, between 2014 and 2015, 13% HIV funding level decrement have been reported
globally (UNAIDS, 2017). This study will contribute to the body of knowledge needed
and significant to the health discipline to address the problem by analyzing the change in
prevalence of HIV in Ethiopia in relation to changes in donors funding levels and
recommend high impact activities with available resources to people with different
socioeconomic and demographic characteristics.
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Background
Ethiopia is the second most populous country in Africa after Nigeria, with a
population of 102 million in 2016 (World Bank, 2017). Despite impressive economic
growth, Ethiopia remains a low-income country with a real per capita income of $505
and 31%of the population lives below the international poverty line of $1.25/day (World
Bank, 2017). According to the UN (2014), Ethiopia ranks 173 out of 187 countries both
the overall index and per capita gross national income (GNI), which shows the country’s
poor economy and general low standard of living. Life expectancy is estimated at just
65.5 years (63.7 for males and 67.3 for females), which gives Ethiopia a world life
expectancy ranking of 141 (WHO, 2018). The inflation of 26% remains a problem for
most poor people and there are thousands of street children in the capital city, Addis
Ababa, alone. It is also one of the least urbanized countries, with 82% of the population
living in rural areas (World Bank, 2016).
The HIV/AIDS situation in Ethiopia continues to be a mixed epidemic with
significant heterogeneity across geographic areas and population groups (Federal
Ministry of Health [FMOH], 2007). The Ethiopia Demographic and Health Survey of
2011 (DHS2011),a nationally-representative household survey that provides data for a
wide range of monitoring and impact evaluation indicators in the areas of population,
health, and nutrition, estimated national HIV prevalence at 1.5%, compared to 2.4% .
Among the surveyed households, 56% of women and 55% of men have never been tested
for HIV (DHS, 2016). This is an indication that the current number of HIV-positive
individuals in the country could be a lot more had all the population been tested.
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Moreover, despite the existence of 1.2 million people living with HIV/AIDS, 72% are
thought to be aware that they are living with the virus; the remaining 28% think they are
not infected (DHS, 2016).
In order to address these problems, HIV care and treatment services have been
expanded rapidly and this was reflected in the massive scale-up of ART access to people
living with HIV from 96,897 in 2006 to 450,000 at the end of 2016 (WHO, 2016). This
success was accompanied by an unprecedented increase in resources from the donor
community (UNAIDS & Henry, 2016). During the time when the nature of the epidemic
and its fueling factors creates a complex challenge to the ability of health and other
sectors to meet the targets and control HIV/AIDS in full, the financial supports from
dedicated donors and the commitment from the government of Ethiopia had enabled the
HIV prevention measures bringing considerable progresses and achieving encouraging
results (UNAIDS, 2013).There are numerous aid organizations in Ethiopia that provide
development aid and address global health and other social and economic development
issues. However, according to UNAIDS (2008), the United States under PEPFAR is now
the largest HIV prevention government donor globally, which accounts for 54% of
international funding. In its first 5years, PEPFAR prevented more than 740,000 AIDSrelated deaths in the African countries in which it worked and had, on average, almost
halved general mortality in people living in these countries (Bendavid, 2012). In
Ethiopia, during 2011 and 2012, total spending on HIV/AIDS was $405 million, of which
86% ($350 million) came from donors and 64.5% of it was from PEPFAR (UNAIDS,
2013).
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While the Ethiopia government is committed to achieving universal access to
treatment for those in need, funding for HIV from PEPFAR has begun to flat line, and
international contributions from other donors is declining while the fund shortage is
increasing exponentially (UNAIDS, 2013). To mitigate this problem, ways of boosting
funding have been dealt among stakeholders in the past by calling for more donor
coordination, increasing traction of donors’ interest by providing empirical evidence that
their donations change lives and make desired impact on the lives of people, and
undertaking high impact targeted HIV prevention activities. Donors’ coordination is
imperative to use available funds for interventions that are cost-effective and capable to
avert a high number of HIV infections compared with uncoordinated uses of the funds
(Kahn & Marseille, 2000).The information recognized on the association between HIV
prevalence and funding levels would provide evidences for the rational allocation of
resources for the right target groups and increases the likelihood of utilizing new funds
efficiently in the future. Otherwise, if funding for HIV remains at its current level or if
PEPFAR, the largest supporter, in the global fight against HIV and AIDS makes drastic
cuts to its level of support, HIV deaths and new infections can be expected to rise in
concentrated, generalized, and hyper endemic settings (Piot, 2015).
As a result of the global response to HIV, 20 million people are now receiving
ART and both new infection and mortality rates have been declining (WHO, 2016); this
was happening mainly because of the support from PEPFAR (Vogus & Graff, 2015).
Conversely, in order to reach the UNAIDS 90-90-90 goals by 2020, which is that 90% of
persons with HIV will know their HIV status, 90% of persons with HIV will receive
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sustained ART, and 90% of persons receiving ART will achieve viral suppression
(UNAIDS, 2017), the available funding for it seems inadequate and threatening the hope
of achieving the goal as it is being declining.
In addition to PEPFAR, funding decrements have been noticed among some
significant global donors including the U.K. Department for International Development
(DFID), the Global Fund to Fight AIDS, Global Fund for Tuberculosis and Malaria, Bill
and Melinda Gates Foundation, and Australia’s Department of Foreign Affairs and Trade
(DFAT; Formerly AusAID) (Kates et al., 2014). The DFID is cutting all of its bilateral
HIV funding to middle income countries (Murphy & Podmore, 2014). From 2010 to
2014, PEPFAR began a transition process in 12 countries in the Eastern Caribbean
(PEPFAR, 2010; Vogus & Graff, 2015) as well as South Africa, Botswana, and Namibia
(Brundage, 2011). The Global Fund for HIV prevention has deemed 11 countries
ineligible for further HIV funding based on their income status and disease burden
(Garmaise, 2015).
Meanwhile, according to Office of Global AIDS Coordination [OGAC] (2016),
even though Ethiopia has focused on efforts that could sustain epidemic control by
decreasing the numbers of new infections and AIDS-related deaths, deficiencies or gaps
have been observed in terms of consolidating gains achieved to date, continuing program
realignment, consolidating implementing partners, and focusing on country ownership.
In addition, there was no study showed how HIV prevalence is associated with donor
funding levels, and what type or/ number of services or responses the country’s strategic
plan should focus on to control the HIV/AIDS epidemic during decrements of funds by
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applying critical enablers like programming in areas such as human rights, communitybased capacity building, targeting, and retention in care.
As a result, at this time, when there is less financial support from external donors,
unless the country develops strategies that can maintain the momentum of success, there
is no guarantee of avoiding a relapse of the epidemic because of funding level
diminishment. Hence, this will be a critical time to target HIV prevention activities with
evidence, establish strong coordination between existing donors, strengthen internal
financial sources, leverage available financial sources, avoid duplication of efforts, and
foster greater transparency to support country ownership. To do this all, analyzing the
trend of HIV prevalence and funding from donors for anti-HIV/AIDS activities and their
effects on health and social outcomes to all socioeconomic and demographic
characteristics is paramount to designate effective measures that could bring desired
changes like reducing death rate due to HIV and controlling the transmission of the virus
with limited resources. Otherwise, insufficient human resources, feeble supply of
management and distribution, and weak midlevel managerial capacity at regional and
district levels will continue challenging Ethiopia’s response to HIV/AIDS.
Accordingly, this study has shown where the HIV epidemic is currently heading
and how this correlated with the funding level allotted every year from the donor
community for HIV prevention, care, and support. In addition, it analyzed whether the
changes in prevalence was statistical significant; evaluated the relationship between the
type/number of services or responses to control HIV/AIDS and the funding levels; and
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examined the difference in prevalence among different socioeconomic and demographic
characteristics.
Purpose of the Study
The purposes of this secondary data analysis, quantitative study, were to explore
if funding level from donors’ community is a proximate determinant for prevalence
change, analyzing if the funding shortfalls threaten the gains made during the life of the
Fund, and also if there is an association between the declining funding level and the
change in prevalence of HIV/AIDS. It also compared the dependent and independent
variables of each research question. The study focused on how the level of funding from
donor communities was changing the quality and quantity of HIV/AID prevention and
controlling activities; and what needs to get prior attention in the national HIV/AIDS
control program when the budget level is continue declining. The approach,
understanding the change in level of funding from donor community, aligns with the
prevention and control measures of HIV/AIDS. This quantitative analysis has helped to
identify the tendency of funding level, and indicated the type and number of services that
need to be provided in high prevalence regions of the country within the available
resources. This study recommended effective HIV/AIDS controlling activities that need
to be given priority in the national HIV/AIDS control program of Ethiopia in resource
constrained settings secondary to the budget reduction or budget cut from the donors’
community.
The potential positive social change implication of this study finding is informing
the healthcare decision-makers with findings of the four research questions so that they
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will place more value on such works in their deliberations and in their interactions with
stakeholders for sustainable financing initiatives. It also will help to bring changes in the
system of implementation; and find the best solutions to HIV epidemic control and
prevention strategies, which is the most burdensome health problems, by meet the longterm needs of people living with problem. In addition, it will have an important role of
supporting the transfer of knowledge between the researcher and healthcare decisionmakers to bring valuable and positive social changes in social structure and lead a more
context sensitive, adaptive, and innovative responses.
The role of donors, especially the PEPFAR, in the Ethiopia HIV epidemic control
is significantly high; and because of such supports, the epidemic in the past decade has
shown a trend of stabilizing and subsequently declined from 12.4% to 1.1% in between
2001 and 2016 in both urban and rural areas where >85% of the population lives (EPHI,
2017). Such changes in trends are encouraging and represent the commitment of the
government and the contribution of collective concerted efforts across the numerous
stakeholders involved in the Mutli-Sectoral HIV/AIDS responses (FHAPCO, 2012).
However, because of a dip in donor HIV spending from $7.7 billion in 2009 to $6.9
billion in 2010, and $4.9 billion in 2016, it becomes clear that many countries’ that heavy
reliance on donor funding could not continue (UNAIDS & Henry Family Foundation,
2017).
Likewise, yearly, more than 86% of the total spending on HIV/AIDS in Ethiopia
was came from external sources; and PEFPAR was the greatest contributor, forming
greater than 50% of total spending on HIV/AIDS (UNAIDS, 2013); however, this
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funding level from PEPFAR-Global Fund peaked in 2010, and has decreased by almost
50 percent since 2012 (Office of the United States Global AIDS Coordinator [OGAC],
2016); and this has negatively affected the interventions.
Accordingly, the finding of this study has answered the research questions and
contributed an effort to the HIV prevention and control program by proposing new
approach on HIV control activities for targeted population groups and better geographic
targeting of resources and a greater focus on the highest-impact prevention strategies that
need to be addressed with limited resources in the process of transitioning away from
reliance on external funding in favor of greater domestic investment for HIV without
significant backsliding away from successes. In addition, it outlined the major areas of
emphasis for future programming based on the review it made on the trend of HIV/AIDS
prevalence among different socioeconomic and demographic characteristics; and donors
supported Anti-HIV/AIDS activities and their effect on health and social outcomes. It
also showed efficient and effective ways in speeding up progress in achieving the
ambitious global targets of zero new infection, zero stigma and discrimination, and zero
deaths due to AIDS with limited or local resources in the study area.
Research Questions and Hypotheses
RQ1: How has HIV prevalence changed in Ethiopia during the past 10years?
H01: HIV prevalence in Ethiopia shows no difference during the past 10years.
Ha1: There is a statistically significant difference between the HIV prevalence of
the past 10years in Ethiopia.
RQ2: How does the trend of HIV prevalence associate with funding from donors?
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H02: There is no relationship between funding from donors and the trend of HIV
prevalence.
Ha2: There is a relationship between donors’ financial support to fight HIV/AIDS
in Ethiopia and HIV prevalence trends.
RQ3: What is the relationship between the type/number of services being
provided to prevent and control HIV/ADS and funding from donors?
H03: The type and number of services being provided to prevent and control
HIV/ADS in Ethiopia have no relationship with the yearly funding levels from the donor
community.
Ha3: There is a relationship between the type and number of services being
provided to prevent and control HIV/ADS in Ethiopia and the yearly funding levels from
the donor community.
RQ4: What was the effect of different socioeconomic and demographic
characteristics on the trend of HIV prevalence in the past 10years?
H04: HIV prevalence in the past ten 10years show similar trends among all
socioeconomic and demographic characteristics.
Ha4: HIV prevalence in the past 10years show different trends among different
socioeconomic and demographic characteristics.
Theoretical Foundations for the Study
The proximate determinant is a quantitative framework that was first applied by
John Bongaarts, a Dutch demographer, in the 1970s (James, 2006). The framework was
used to study the relationship between factors, biological and behavioral, that impact
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fertility including economic and environmental variables; and in turn, these external
variables influence fertility. Bongaarts established an equation to define the impact of the
most important proximate determinants on the outcome. This frame work has been
applied broadly in the study of fertility and child survival in developing countries
(Boerma & Weir, 2005). The key to the Proximate Determinant framework is recognizing
of a group of variables that can be affected by changes in related variables or by
interferences that have immediate effects on outcomes. According to James J C. (2006),
the proximate-determinants framework can be used in HIV/AIDS study design, risk
factors analysis and interpretation of findings. Accordingly, in this study, the proximatedeterminants framework has been applied to examine the prevalence of HIV/AIDS and
funding level from donors for Anti-HIV/AIDS activities. The rational for choosing this
framework was because it examines the association of proximate variables, like funding
level for Anti-HIV/AIDS activities, with prevalence and if that has a direct effect on
other outcomes and influences the change of other variables. The framework incorporates
terms that are easily interprets and has been widely utilized as a theoretical model for
HIV prevention and health promotion.
This study was a trend analysis of HIV prevalence using secondary data from
demographic and health surveys (DHS) done between 2005 and 2016, and from
expenditure analysis data from HIV/AIDS program implementing partners in Ethiopia,
and from data base of some health facilities. After considering the complexity of this
study, the data were analyzed for each research question independently from different
sources. The trend analysis model was useful, from national level perspective, guiding
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the understanding to promote for targeting the right persons by examining whether the
prevalence changing over time, and whether these trends differ among the predominant
age, sex, racial/ethnic groups and be affected disproportionally by the HIV epidemic. It
also enhances country ownership, creating a resilient system during budget cut, which
ultimately enable to select the right HIV/AIDS responses for the right target groups.
Characteristics

Individual factors
e.g. unprotected
sexual activity, illicit
drugs, poor condom
use etc.

Social factors
E.g. Population
growth, migration,
stigma &
discrimination.

Proximal determinants

Outcome

HIV/AIDS
infection

Funding
level from
donors
community

Diseas
e
Mortalit
y

Health Factors

Blood safety practice
Poor access to condom
Poor access to ART
Poor access to testing
Less Health Education
S
TI
Ed

Accessibility

Figure 1.Conceptual framework on the proximate determinants of HIV prevalence trend.
Nature of the Study
This was a descriptive and correlational study that used a quantitative research
method for quantitative variables (HIV/AIDS prevalence, PEPFAR Funding level,
demographic characteristics, etc.) to determine if there is a relationship between the
prevalence of HIV/AIDS in Ethiopia and the declining funding level from donors.
Information on different years’ funding level from donors to prevent, treat, and control
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the HIV/AIDS epidemic in Ethiopia was used from secondary data sources. The data on
amount of funding levels from major donors focused on HIV/AIDS in the mentioned
period were obtained from the data base of Federal Ministry of Health (FMoH) and
FHAPCO. Accordingly, the necessary data collected from these institutions had enabled
the researcher to answer the research questions including whether the donors support to
fight HIV/AIDS was related to the prevalence or burden of the disease or not. In addition,
a ten-year expenditure data from major program implementing partners were analyzed to
know if the type and number of services to prevent and control HIV/AIDS were
considering the variation of funding levels of each year or whether that was similar in all
years by comparing services provided to different population groups.
To see any alteration in the HIV/AIDS prevalence in the past ten years in relation
to socioeconomic and demographic characteristics, data collected by Central Statistics
Agency (CSA) for Demographic and Health Survey (DHS) 2005, 2011, and 2016 were
used. In addition, The records of 1000 pregnant women 15 to 24-Year-Old attending two
ANC clinics of public health facilities in Bishoftu and Addis Ababa from January 2006 to
June 2016, and screened for HIV antibodies, were analyzed to see the trend of HIV/AIDS
prevalence and to triangulate the result from DHS data findings. Equally, the sociodemographic, behavioral and HIV-related data were analyzed using regression and
bivariate and multivariable analyses were conducted to determine the factors that are
independently associated with HIV-positive status. Data were analyzed using SPSS
version 24.

18
The researcher’s rationale behind selecting these design and data sources was that
both were readily available, quickly obtainable, and economical. Furthermore, using
these secondary data from different sources helped to triangulate findings, improved the
understanding of the problems. It also provided a basis for comparison of the data
collected in different years so as to answer the research questions well.
Literature Search Strategy
The process of literature review for this study included assessing pertinent peerreviewed articles from the globe, Africa, and Ethiopia using both manual and electronic
exploration methods. Different search engines and databases like: UNAIDS/WHO
Global HIV/AIDS Online Database, U.S. Census Bureau HIV/AIDS Surveillance Data
Base, MEASURE/ORC MACRO Demographic and Health Surveys, the Ethiopia
Demographic and Health Survey [EDHS] database, Medline, PubMed, Google Scholar,
and Popline/One Source were used to search and identify appropriate studies. The
websites of different organizations and other relevant sources were also explored
manually. The search for appropriate studies used terms like prevalence, funding,
services, HIV, response, socioeconomic, demographic, Spending, trend, donors, and
other combinations: most-at-risk populations, vulnerability, HIV/AIDS, trend-analysis,
Anti-HIV/AIDS, prevalence –rate, AIDS-Spending, and PEPFAR-spending.
Literature Review
Prevalence Changes
HIV continues to be a major global public health issue. In 2016, an estimated 36.7
million people were living with HIV (including 34.5 million adults, 17.8 million women
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(15+ years), and 2.1 million children (<15 years) – with a global HIV prevalence of 0.8%
among adults (UNAIDS, 2017). Around 30% of these same people do not know that
they have the virus (UNAIDS, 2016).
Since the start of the epidemic, an estimated 76.1 million people have become
infected with HIV and 35 million people have died of AIDS-related illnesses. In 2016, 1
million people died of AIDS-related illnesses (UNAIDS, 2017), and 1.8 million people
became newly infected. There has previously been concern that the annual number of
new infections among adults would remain static, as incidence rates failed to shift
between 2010 and 2015; while new HIV infections among children globally have halved,
from 300,000 in 2010 to 160,000 (47%) in 2016(UNAIDS, 2017). However, a slightly
positive trend is emerging as new infections among adults are now estimated to have
declined by 11% (1.9 million to 1.7 million) - and 16% for the general population between 2010 and 2016, whereas there was only an 8% decline between 2010 and 2015.
As of June 2017, 20.9 million (56.9%) people (54% of adults aged 15 years and
older and 43% of children aged 0–14 years) were accessing antiretroviral therapy (ART).
In 2016, the percentage of pregnant women living with HIV who accessed antiretroviral
medicines to prevent transmission of HIV to their babies was 76%. As a result of the
improved coverage of ART and other HIV services, death rate due to AIDS has declined
globally from 2005 to 2016 by 48% (1 million died in 2016 while it was 1.9 million in
2005) (UNAIDS, 2017).
Almost all countries worldwide are affected by the HIV epidemic. No region of
the world has been spared. Although the epidemic is global, there is a remarkable
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regional variation in its distribution. Some regions are highly affected by the epidemic as
compared to other regions. The vast majority of people living with HIV are located in
low- and middle- income countries, with an estimated 25.5 million living in sub-Saharan
Africa. Among this group 19.4 million are living in East and Southern Africa which saw
44% of new HIV infections globally in 2016(UNAIDS, 2017).
Sub-Saharan Africa (SSA) is also one of the hot spots where HIV AIDS is widely
spread and it is more hard hit by the consequences of epidemic than other parts of the
world. It is the region where the highest number of victims of HIV/AIDS is found. Out of
the 36.7 million people living with HIV worldwide, 69% live in sub-Saharan Africa
(UNAIDS, 2017). There are roughly 23.8 million infected persons in all of Africa (WHO,
2015), and 91% of the world’s HIV-positive children are also in this continent.
According to the United Nation classification of ‘generalized epidemic’ about 90% of the
countries which are located in Sub-Saharan Africa are severely affected by the epidemic.
This epidemic has remained the major cause of death in this region.
Although the Africa accounts only for 16.6% of the world population
(Worldmeter, 2018), two-thirds of the total people living with HIV (24.5 million) are
Africans, of whom 15 million have already died. Sub-Saharan Africa carries a
disproportionate burden of HIV, accounting for more than 70% of the global burden of
infection. Of the estimated 1.8 million individuals worldwide who became newly infected
with HIV or from the 5,000 new infections per day, two out of three are in sub-Saharan
Africa with young women continuing to bear a disproportionate burden (UNAIDS,
2016). The newly infected children (<15 years) with HIV includes 160,000 and most of
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these children live in sub-Saharan Africa and were infected by their HIV-positive
mothers during pregnancy, childbirth or breastfeeding.
In eastern and southern Africa young women (aged 15–24 years) remain at
unacceptably high risk of HIV accounted for 26% of new HIV infections in 2016 (WHO,
2016). Countries in North Africa and the Horn of Africa have significantly lower
prevalence, as their populations typically engage in fewer high-risk cultural patterns that
have been implicated in the virus's spread in Sub-Saharan Africa (Gray, 2007). Southern
Africa is the worst affected region on the continent (UNAIDS, 2012). As of 2011, HIV
has infected at least 10 percent of the population in Botswana, Lesotho, Malawi,
Mozambique, Namibia, South Africa, Swaziland, Zambia, and Zimbabwe (UNAIDS,
2012).
Meanwhile, with increasing access to ART, the number of AIDS related deaths
have steadily declined and in sub-Saharan Africa these decreased by 39% between 2005
and 2013 (UNAIDS, 2015). In South Africa alone the decline was 51% whereas in
Ethiopia it was 37% and in Kenya it was 32%. Several empiric studies from South
Africa, Uganda, Tanzania, Rwanda and Malawi have demonstrated that the impact of
modest ART coverage at CD4 cell counts ranging from <200 to 500 cell per µl resulted
in significant declines in mortality with life expectancy increasing by an additional 10
years (Herbst, 2009).These studies provide evidence on the benefits of early ART
initiation to HIV positive individuals.
HIV/AIDS was first recognized in Ethiopia in the year 1984 (HAPCO, 2005), and
the first hospitalized AIDS patients informed in 1986 (Lester, 1988). During those early

22
times, the epidemic was restricted only in urban areas and among certain population
groups in specific commercial routes. Four years later, high HIV prevalence noticed in
commercial sex workers and distance truck drivers, which were 17% and 13%,
respectively (Mehret, 1990). A prevalence of 24.7% was also reported among sex
workers of some urban areas in 1988 and this number rose rapidly in Addis Ababa to
54.3% in 1990 (Mehret& Khodakevich,1990). Since then, the epidemic has expanded
throughout the country both in rural and urban area and by the end of 1999, about 3
million people were infected with the virus and made the population the third largest
infected globally next to South Africa and India (UNAIDS 2000).
The mode of transmission of the virus in Ethiopia is largely through heterosexual
contact and mother-to child transmission with the highest prevalence of infection in the
age group of 20-39. Younger age females are also more affected and susceptible for
HIV-1 subtype C virus than males (Abebe, 2001). According to AIDSCAP (2001),
exacerbating factors for the rapid spread of HIV are: a) cyclical relocation of workers in
hunt of employment, which expose them for extramarital sexual intercourse and multipartner sexual contacts, b) unrest and instability as a result of civil war, c) high
prevalence of sexually transmitted diseases in high-risk susceptible groups, d) early
sexual debut among youth, and e) huge unemployment rate in the country.
In 1998, the peak HIV prevalence was in the age group 25–29 years, being 16.3%
(Fontanet, 1998). For the age group 15-49, the prevalence had shown a decreasing
fashion like 2.2% in 2005, 1.4% in 2010, and 1.1% in 2015 (UNAIDS, 2016). In general,
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the HIV prevalence levels for both men age 15-59 and women age 15-49 rise with age,
but the peaking among women is in late 30s while for men is early 40s (EDHS, 2016).
In 2011, the overall HIV prevalence was 1.5% with 1.9% among females and
1.0% among males (EDHS, 2011). Five years back, the prevalence of HIV in women was
2%, while for men age 15-49 was 1% (EDHS, 2005). According to the Ministry of
Health of Ethiopia, the Spectrum Model estimation of HIV prevalence for the year 2012
showed 1.3% overall, 1.8% for females, and 0.9% for males (FMOH, 2012). The most
recent 2016 Ethiopia EDHS reported, the prevalence of HIV in women increases with
age, affecting 0.4% of women age 15-19 and 3.0% of women age 40-44, before declining
to 1.9% among those age 45-49 (EDHS, 2016).
In 1994, data from 11 urban blood bank centers showed that the prevalence of
HIV varied from 5–20%, being 6.6% in Addis Ababa (National Blood Transfusion
Service, Ethiopian Red Cross Society, personal communication, 1994). There is also
prevalence difference in between urban and rural dwellers for both sexes. The prevalence
of HIV for women was decreased from 7.7% in 2005 to 3.6 in 2016. Likewise, the
prevalence for men was also decreased from 2.4 to 0.2% in 2005 and 2016, respectively
(EDHS, 2005; EDHS, 2016). In the regions of Ethiopia, there is extensive prevalence
difference, 6.6% in Gambella, 5.0% in Addis Ababa, and 0.7% in Southern Nations,
Nationalities and Peoples’ region (SNNPR).
High rates of HIV prevalence were soon detected along the main trading roads of
the country, with HIV seroprevalence of 17% among commercial sex workers and 13%
among truck drivers working along these roads in 1988. However, by 1998, HIV
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prevalence among sex workers attending STD clinics had increased to 73% (Aklilu,
2001). Next to sex workers, long distance truck drivers are known to be at increased risk
of HIV infection and their HIV prevalence in 1988 was 13% (Mehret, 1990).
Unsolved Issues about Prevalence Changes in the Literature
According to UNAIDS and WHO (2007), HIV prevalence is the proportion of
people living with Human Immunodeficiency Virus (HIV), which is estimated to be
about 0.5% of the world's population. To get the national HIV prevalence, a number of
approaches are being used including: surveys, sentinel surveillance data in ANC, surveys
of particular high-risk groups like sex workers, and using secondary data from national
HIV/AIDS registries. Meanwhile, in the literatures reviewed, even though there are a lot
evidences showing that the prevalence of HIV in Ethiopia is in a decreasing fashion for
different community groups, not adequate evidence obtained to show whether the HIV
prevalence changes are valid in a statistical sense. In addition, there is little evidence to
show where the epidemic is heading with different socio economic and demographic
characteristics. Accordingly, this study has answered if the HIV prevalence changes in
the country are valid in a statistical sense so as to show where progress is being made in
controlling the epidemic, and where priority in the national HIV/AIDS control program
should be made in resource constrained setting.
Funding from Donors
Even though a substantial development has been found in combating HIV/AIDS
(UNAIDS, 2017), by allocating a significant amount of resources, the problem still
creates very big challenges and remains an international emergency (United Nations
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General Assembly, 2016). The continuing resource gap is one of the challenges.
According to UNAIDS, even if US$19.1 billion was accessible from both international
and domestic sources to address HIV in low- and middle-income countries in 2016
(UNAIDS, 2017), US$26.2 billion will be wanted yearly by 2020 to end AIDS as a
public health threat globally by 2030 (Izazola, Loures, & DeLay, 2016).
In low and middle income countries, funding from donors represents the major
share of the entire expenses for HIV; however, funding from all sources is very important
to attain more progresses. In 2016, the donor funding in low- and middle-income
countries for HIV decreased by $511 million (from US$7.5 billion in 2015 to US$7.0
billion), which is a 7% decrement, and made it the lowest level disbursements since 2010.
The reasons for the declining funding level were several including the one that accounts
for the 50% decline - decreases in both bilateral and multilateral funding, exchange rate
variations accounts for the 20% decline, malaria and tuberculosis accounts for 30%, the
timing of U.S. contributions to the Global Fund to Fight AIDS, and due to U.S. law that
limits its funding to one-third of total contributions to the Global Fund (Jen & Adam,
2017). The 2016 decline is due to several factors: actual decreases in both bilateral and
multilateral funding, accounting for an approximate net 50% of the decline; exchange
rate fluctuations.
HIV remains the second cause of mortality and morbidity in sub-Saharan Africa
(Murray et al., 2012). One of the highest HIV prevalence in the world is in Sub-Saharan
Africa, which is 5% and it alone makes up two-thirds of the worldwide HIV burden.
About 5.7 million HIV-positive adults are living in South Africa. In 2003, PEPFAR
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provided 60% of the bilateral assistance to 15 countries of Africa namely: Botswana,
Cote d’Ivoire, Ethiopia, Guyana, Haiti, Kenya, Mozambique, Namibia, Nigeria, Rwanda,
South Africa, Tanzania, Uganda, Vietnam, and Zambia. In 2007, the adult prevalence in
these countries were varied from 0.5 to 23.9% though courageous measures are being
taken by most HIV-affected sub-Saharan Africa countries, generating adequate public
resources for HIV prevention, care, and support activities couldn’t be possible; and
hence, substantial international funding remains essential for years to come. On the other
hand, increasing the government revenue-raising and mobilizing exceptional resources in
relation to the epidemic control is becoming important in low and middle-income
countries.
According to UNAIDS (2014), the resource needed by 2015 for the HIV response
and reducing the number of new infections and AIDS related deaths is about US$22–24
billion. To significantly decrease the AIDS deaths by 90% and scale up the HIV
responses by 2030, US$36 billion is estimated to be secured. So far, international
financing serves are the substantial source of funding for HIV expenditure. However,
because of enthusiastic economic growth predictions and augmented incomes from
natural resources HIV funding from external donors is becoming flat-lining (Vassall et
al., 2013); and hence, many international and provincial statements have called for
governments to fund their own HIV responses (Buse & Martin, 2012; Galarraga et al.,
2013; Resch et al., 2015), which on the other hand inform donors to relocate their funds
on countries that most need outside supports (Resch et al., 2015).
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The U.S. and Global Fund are the largest donors of HIV programs in Africa
accounting for 83% of the total funding. However, U.K., World Bank, and Sweden are
among the five top contributors of the continent. According to Avert (2012), most of the
HIV and AIDS funding is used for ART, HIV testing and counseling (HTC), Prevention
of mothers - to-child transmission (PMTCT), condom use and distribution, voluntary
male circumcision (VMMC), HIV education, and HIV awareness.
In the past decade, donors supported Anti-HIV/AIDS programs in Ethiopia has
been fueling the rapid scale-up services with significant positive effects like dropping
rates of new infections and prevention of millions deaths (UNAIDS 2011). Until 2011,
Ethiopia has been supported from PEPFAR by more than $1.4 billion and by Global
Fund with total disbursements of $1.16 billion, which made Ethiopia one of countries
received more funding. The PEPFAR-Global Fund increased in 2010, but reduced almost
by 50% as of 2012. Nowadays, there is a cliff in AIDS spending and the government of
Ethiopia is in a free fall. Since 2013, Ethiopia has experienced a 79% HIV/AIDS budget
reduction from PEPFAR because of HIV prevalence reduction and due to
epidemiological trend changes. In only a year time, from 2012 to 2013, PEPFAR funding
decreased by US$191 million.
In 2008, more than 20% expenditure for other health programs was supported
from AIDS funds; and almost 84% of it was also externally funded. Taking this all in to
consideration, though the government of Ethiopia increased public spending, making
significant new public funding to health was becoming unlikely because of the low
revenue to GDP ratio and high inflation in the country. Accordingly, in spite of many
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steps have been taken to improve the health of the people in the last decade, the people
still suffer from different diseases and deaths. About 350,000 children die every year and
majority (90%) of these deaths is due to easily preventable diseases viz., HIV/AIDS,
pneumonia, malaria, diarrhea, and malnutrition. In addition, more than 90 % of new
births are conducted in homes without skilled health professionals.
Unsolved Problems about Funding from Donors in the Literature
Even though there is a progress in relation to HIV prevalence in the country, the
per capita income may not be adequate to run the started HIV activities effectively; and
there is a fear to face serious health challenges if the external funders are not willing to
continue supporting and able to sustain existing AIDS programs. The nearly 800,000
people living with HIV, the second-leading cause of death in the country after respiratory
infections, may get shortage of accessing ART. An extraction of donor financing, without
a compensating domestic financing response, may damage the stability of care for those
on ART, and creates huge opportunity costs by shifting fund from other programs run by
domestic expenditures. Unexpectedly, some of the other programs run by domestic
expenditures may also critical for the success of HIV responses. Accordingly, this study
has tried to answer how the decreasing funding levels from the donors’ community is
affecting the HIV prevalence and given recommendations on how the country finance its
cost effective and efficient responses from domestic sources.
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Type/Number of Services or Responses to Prevent and Control HIV/ADS and the
Funding Levels from the Donors
In 2016, 19.5 million people living with HIV were receiving antiretroviral
treatment (ART) - up from 17million in June 2016 and 7.5 million in 2010. If this level of
treatment scale up continues, it is estimated that the world will meet its global target of
30 million people on treatment by 2020 (UNAIDS, 2017). According to WHO (2015), a
number of vital performance indicators are being used to assess the attainment of ART
programs. These performance indicators are: access, coverage of and equity for ART;
timely initiation of ART for eligible; retention in care; and tracing of people with
treatment failure and switching them to second-line regimens. In the past decade, these
indicators were utilized by Ethiopia to monitor and evaluate the performance of its ART
program (Assefa et al., 2010; Federal HIV/AIDS Prevention and Control Office, 2013).
Ethiopia as the second populous country in Africa, the per capita income is $505
and 31% of the people are living below the poverty line, which is $1.25/day; and hence,
the country ranks 173 out of 187 countries in per capita Gross National Income (UN
Human Development Index, 2014). However, the government of Ethiopia has shown
strong commitment in responding to the HIV/AIDS epidemic since the first AIDS case
was identified in 1984. The government has led a multi-sectoral response which engages
government sectors, development partners, civil societies, and the private sector, for
which the required governance structures, policy environment and systems for
monitoring and evaluation were established and progressively improved based on lessons
learnt from experiences.
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The response has also required significant resources which have been invested
from government, development partners and civil societies. According to WHO (2013),
Ethiopia expends 3 to 5 percent of the Gross Domestic Product (GDP) on health while
the foreign sources funding 30 to 50 percent; meanwhile, the annual per capita health
spending is less than $25. In 2012, the total money spent for HIV/AIDS in Ethiopia was
US$ 405 million; of which, US$ 350 million (86%) obtained from external sources,
US$55 million (13%) from public income and US$ 680,000 (0.2%) from the private
sectors. The proportion of spending the 2012 budget by regions shows that 43% was
expended by federal/central government, 13% in Amhara, 13% Addis Ababa, 11%
Oromia, 8% South Regions, and 22% for the remaining seven regions or towns (MOH,
2014).
In Ethiopia, the key sources for HIV/AIDS are public (mainly from federal level)
and external sources (NHA, 2011). The MOH’s expenditure in 2012 for HIV/AIDS
prevention and public health, outpatient and inpatient care, research, training,
pharmaceuticals, and health administration was about 47 million. The second source of
fund, mainstreaming fund, was contributed 3.5 million from sectoral ministries by saving
2% of their budget. In 2012, Ethiopia had external sources of fund, US$350 million, for
HIV/AIDS prevention, care, and support programs from different governments including
Canada, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Spain, Sweden, United
Kingdom, and USA. In general, from external funds for HIV/AIDS, 59% was from
government of USA, 30% from global fund, 7% from non-profit international
foundations, and 4% from all other externals. Among the total funds obtained from
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external sources for HIV/AIDS, 37% managed by the Government of Ethiopia, 60% by
external agents, and 3% by private entities (UNAIDS, 2013). In relation to expenditure of
money from all external sources by thematic area, HIV treatment, prevention, national
system strengthening and Program coordination, and OVC support share the 30.9%,
19.5%, 29.7%, and 6.8%, respectively (FHAPCO, 2012). On the other hand, 26%, 21%,
26%, and 27% of the PEPFAR fund from 2010 to 2017 was used for prevention, care,
treatment, and national system strengthening and governance, respectively.
Nowadays, international assistance is essentially flat and some donor countries
are reducing their funding (UNAIDS, 2012). Likewise, though the US federal funding for
HIV has increased significantly over the course of the epidemic by $5.7 billion (or 20%)
when comparing the FY2017 request (34 billion) to the FY 2011 enacted funding level
(28.3 billion), funding to address HIV in Ethiopia from PEPFAR was declined since
2010. In 2010, Ethiopia had $291million annual funding from PEPFAR while this
amount decreased to $185 billion in 2012, $160 billion in 2013, $126 billion in 2014, and
$100 million in 2018. PEPFAR, the commitment of America, is supporting to save lives
and realizing an AIDS-free generation globally. Funding from other donors including the
United States was also either deteriorated or continued flat. The type of assistance from
the donor community includes cash transfer, technical assistance, or commodities.
Meanwhile, for all sort of assistance, US is the largest donor in the globe that covers
about 65% of the HIV expenditures by donor governments. The second and third donors
are U.K. and France cover 12.9% and 3.7% of the HIV expenses, respectively.
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Unsolved Issues about Type/Number of Services and Funding Level
According to HIV domestic priority index of UNAIDS (2010), for middle-income
countries, to fund its own HIV responses and curb the HIV epidemic, their domestic
spending should be increased sustainably; or the funds from international donors needs to
be coordinated. Like any sub-Saharan Africa countries, Ethiopia is highly dependent on
donor funding and increases worries about the sustainability of its national HIV response
(Haacker, 2009) as funding scarcities will have a contrary impact to what has been
achieved so far. In order to address the problem related to funding level decrement,
vigorous financial tracking system should be in place to understand the funding trends
and its relationship with type/number of services or responses to prevent and control
HIV/ADS. Knowing the funding level and the type/number of services is critical so as to
evaluate the spending patterns and to scale up high impact and effective interventions
without interruptions of antiretroviral treatment (ART) and other amenities.
Accordingly, this study examined if there is an association between the declining
funding level and the change in HIV prevalence, and whether the funding shortfalls is
potential to threaten the gains obtained so far to control the virus. The study has also
recommended further studies to identify some specific high impact interventions to
address some targeted groups with low funding level; and show the need of sustainable
domestic investments to have robust response to the HIV epidemic.
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Prevalence of HIV/AIDS with Different Socioeconomic and Demographic
Characteristics
Despite the fact that enormous people living with HIV are living in low- and
middle- income countries, no county in the world is free from the impact of HIV/AIDS;
and cure and vaccine are still distant hopes. One of the reasons that made the prevention
and control measures of HIV much more complex is that factors exacerbating the
transmission of virus from one person to another are more private, which can be
socioeconomic, socio-cultural and/ or epidemiological (Bonnel, 2000). Knowing these
determinant factors is very important so as to design effective responses.
A long-held belief on HIV/AIDS is HIV epidemic is derived by poverty.
UNAIDS also stated as poverty and underdevelopment aggravate HIV epidemic
(UNAIDS, 2001). According to Fenton L. (2004), people practice high-risk behaviors if
they are poor; and hence, reducing poverty is the only long term feasible solution to end
the epidemic. As UNDP states, poverty comprises deficiency, controlled choices, and
unsatisfied competences, and raises to interconnected features of well-being that
influence the quality of life (UNDP, 2020). Poverty doesn’t essentially restrict to
financial capital, enumerated, and reduced in monetary indices. While money is
significant, lack of non-monetary resources also leads to sustains poverty (Shelton, 2005),
and many people in Africa are in such poverty lacking assets and skills in addition to
money. Accordingly, to have basic needs, they indulge into risky sexual behaviors to earn
their breads. In a study done to see the prevalence of HIV in eight African countries
(Ghana, Kenya, Lesotho, Burkina Faso, Malawi, Cameroon, Uganda, and the United
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Republic of Tanzania) by wealth group, the study finding indicated as there is positive
association between household economic status and prevalence (Mishra, 2007).
According to Hallman K. (2005), poor people usually undertake particular risky practices
like earlier sexual debut.
As the result of insufficient financial and little assets poor households are
marginalized socially, politically and excluded; and hence, these people are hard to reach
for programs aimed to teach on sexual and other behaviors (Cohen, 1998); and incline to
lack sufficient information. Poor people also have poor access to health services and
nutrition; and can’t get treatment for STIs easily. According to Lurie (1995), health
services impacts on HIV/AIDS epidemic is the non-treatment of STIs. They are
biologically more vulnerable to HIV infection because of the weaken immune system
(Stillwaggon, 2002).
Gender discrimination empowers women and creates unfavorable environment
fueling the evolution of HIV pandemic. If there is gender discrimination or inequality,
women can’t negotiate for safe sexual intercourse even with HIV infected partner. The
level of education is also one of the determinants of HIV infection. Though in subSaharan Africa, at the beginning of the HIV epidemic, the infection infects and affects
regardless of people’s educational status, less educated were highly susceptible and
severely affected by the virus. Therefore, many study findings have shown that HIV
infection goes hand in hand with higher socio-professional group, because they are better
informed on preventive measures.
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For economic reasons, people move from place to place and migrant workers
placed themselves in isolated areas where they can’t get adequate information and meet
their regular sexual partners for a long time, which expose them to unprotected sexual
practices. Commercial sex work is also a common practice in such areas for economic
motives. Governance or the attentions of governments that give due attention to
HIV/AIDS influence the trend of the epidemic; because to invest in HIV/AIDS
prevention and control activities, good governance that incited to invest enough in
HIV/AIDS and can make decision is pivotal. If a country has devastating economic
situation and corrupted political environment, the epidemic is likely to scale up.
Another factors demonstrated for having impact on HIV transmission include
condom use and male circumcision. Condom protects the transmission of virus from a
non-protected sexual intercourse between individuals. Male circumcision, prepuce
removal for men, also showed positive impact on HIV transmission approximately 60%
(WHO, 2015).
Definitions
Bilateral support: Bilateral aid represents flows from official (government) sources
directly to official sources in the recipient country (UNAIDS, 2005).
Demographic characteristics: Statistical data about the characteristics of a
population, such as the age, gender and income of the people within the population
(WHO, 2013)
Demographic variables: Characteristics of the aggregate population that marketers
use to segment the market, including age, ethnicity, income, education, gender, and race.
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Education status: The status of a citizen of a country or state in relation to education
or training defined in governmental law or legislation which could be school education,
college education, university education, apprenticeship scheme, training course or
another defined and appropriate status definition.
HIV/AIDS prevalence: Refers to the percentage of people tested in each group who
were found to be infected with HIV (UNAIDS, 2005).
Household income: Household income is a measure of the combined incomes of all
people sharing a particular household or place of residence. It includes every form of
income, e.g., salaries and wages, retirement income, near cash government transfers like
food stamps, and investment gains.
Multilateral support: Represents core contributions from official (government)
sources to multilateral agencies where it is then used to fund the multilateral agencies'
own programs (UNAIDS, 2005).
PEPFAR funding: The President's Emergency Plan for AIDS Relief is an
Emergency Plan a five-year bilateral commitment by the United States Government to
support HIV/AIDS prevention, care and treatment programs in developing countries
(PEPFAR, 2016).
Prevalence: Prevalence is a term used in epidemiology to describe the proportion of
a population identified as having a certain condition (such as HIV). The prevalence figure
is determined by comparing the number of people found to have the condition with the
total number of people in that population group.
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Proximate determinants conceptual framework: A framework provides guiding
principles upon which socio-economic and socio-cultural variables affect HIV prevalence
through biological behavioral factors.
Single point estimate: An estimate of unknown population parameter by using
sample data to calculate a single value.
Socioeconomic: Relating to or involving a combination of social and economic
factors. It is related to the differences between groups of people caused mainly by their
financial situation (Shelton, 2005).
The 90-90-90 Goal: The UNAIDS target to diagnose 90% of people living with
HIV by 2020; put 90% of diagnosed people on antiretroviral treatment by 2020; and to
suppress viral load of the 90% of people in treatment with fully by 2020(UNAIDS,
2016).
Assumptions
One of the assumptions of this study was that the proximate determinants
framework evaluated if the decrement of funding level from donor community was one
of the risk factors of HIV spread and change in prevalence. Though the distribution and
determinants of HIV infection comprised a lot of factors like socio-behavioral,
epidemiological, and biomedical factors, the importance of the role of underlying
socioeconomic and cultural determinants has been increasingly acknowledged (Aral&
Holmes, 2006). Therefore, Key to the framework was the identification of a set of
variables called proximate determinants that can be influenced by changes in contextual
variables or by interventions and that has a direct effect on prevalence. In addition to this,
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it was assumed that the findings on HIV prevalence from 2005 to 2016 from the Ethiopia
Demographic and Health Survey (EDHS), which was implemented by the Central
Statistical Agency (CSA), collected and analyzed the blood specimen as per protocol
based on the anonymous linked protocol developed for The DHS Program and data were
not manipulated or forged.
Scope and Delimitations
In this study, the major issue addressed was the trend of HIV prevalence and its
association with funding levels from donors’ community. The reason for choosing this
specific focus was to know the potential repercussion of the ongoing financial support
reduction for HIV/AIDS response in the country (Garmaise, 2015) and the consequence it
may create on the availability of ant-AIDS drugs and related prevention and care supports
being given to millions of people.
The scope/ boundary of this study was the inclusion of information of people,
adult male and female population ages 15-59 years, participated in EDHS 2005/11 and
2016 from the areas where the PEPFAR programs operates, tested for HIV, and had
received HIV results. Meanwhile, this study didn’t cover the reason for prevalence
changes over the year as well as the change of prevalence in areas where donors’
supports were not available from the beginning. Furthermore, as DHS doesn’t target
children under 15 for HIV test, the trend analysis report in this study don’t have
connection to this age group. The philosophical framework, proximate determinants,
which has been used, also delimited the study as it determines the indirect determinant
variables and delineates the population. Therefore, the result of this study could be
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generalizable only to the PEPFAR program supported areas of the country and to the
population groups from age 15-59 years.
Significance of the Study
The potential contribution of this study is examining the trend of HIV prevalence
in the country as well as in each region from 2005 to 2016 vis-à-vis funding levels
expended from donors’ community for the HIV prevention, care, and treatment services.
In addition, the correlational analysis that was operated will inform the healthcare
decision-makers whether there is an association between trend of HIV prevalence and
funding levels; and if looking for sustainable financing initiatives is required. The
findings could also deliver ideas if policy revision or formation is needed to target
selected HIV/AIDS controlling activities in the national HIV/AIDS control program of
Ethiopia in resource constrained settings secondary to the budget reduction or budget cut
from the donors’ community; and contribute evidence for strategic advocacy for social
change in terms of domestic resource mobilization.
Summary
The first section included a review of the problem statement that build up on
previous research findings, the research questions and hypotheses, literature associated
with Prevalence changes and trend of funding levels from donors’ along with unsolved
and unresolved issues in the literature. Concise definitions of variables and assumptions
that are critical to the meaningfulness of the study have been included sequentially.
Boundaries of the study that identifying populations included and excluded are also
illustrated. Furthermore, the application of the proximate-determinants as the theoretical
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framework has been justified. Finally, brief summary of the methodology and rational for
choosing the design have been discussed. The next section presents the research design
and data collection.
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Section 2: Research Design and Data Collection
The purpose of this study was to examine HIV/AIDS funding from donors, and
analyze if funding shortfalls threaten the gains made regarding HIV prevention strategies
and whether there is an association between the prevalence of HIV/AIDS and declining
donor funding in Ethiopia using the proximate-determinant framework. In this study, I
reviewed and analyzed three national surveys, demographic and health surveys done
between 2005 and 2016 with interval of 5 years, secondary data from two ANC clinics of
public health facilities, and the expenditure analysis data from HIV/AIDS program
implementing partners; and in this section, five main sub-sections have been described:
namely, Research Design and Rationale, Secondary Data Analysis Methodology,
Measurements for Variables, Data Analysis Plan, and Ethical consideration.
Research Design and Rationale
This is a quantitative study which used secondary data from EDHS, expenditure
analysis data from HIV programs implementing partners, and health facility reports on
HIV test results to examine the associations between the independent and dependent
variables as well as HIV prevalence, funding, and trends. As there were more questions
that the study needed to answer, multiple dependent variables were used for multiple
measures. Accordingly, for research #1 (RQ1), the hypothesis of difference in prevalence
among different regions was calculated, and Patterns were displayed by plotting HIV
prevalence against years; for research #2 (RQ2), the dependent variable (the outcome)
was funding level from donors whereas the independent variable (explanatory variable)
was the HIV/AIDS prevalence; for research #3 (RQ3), the dependent variables were
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Types/ number of services while the independent variables were the funding level from
donors and HIV/AIDS prevalence; for research #4 (RQ4),the dependent variable was the
HIV/AIDS prevalence while the independent variables were the socio
economic/demographic characteristics including: age, sex, current marital status,
educational status of sampled people, employment status, number of lifetime partners,
place of living, wealth quintile, and age at first sexual intercourse. Reasons for studying
this were to know how HIV prevention and controlling activities are affected by changes,
which is declining, in funding from HIV programs donor communities and indicate what
the national HIV/AIDS control program should give prior attention in Ethiopia while
external budget support is declining. The rationale for using secondary data in this study
to measure HIV prevalence and yield was that its analysis was a more convenient as the
data were available, economical, and don’t need more time for data collection.
Secondary Data Analysis Methodology
Population
As all women between15 and49 and all men between15 and 59 were the target
population for the three DHS conducted in Ethiopia, this study targeted these groups of
men and women along with their socioeconomic and demographic characteristics, HIV
testing results, and types of HIV prevention services received. In addition, to analyze the
trend of HIV/AIDS prevalence among 15 to 24yearsold pregnant women, ANC databases
of two public health facilities in Ethiopia were used. Even though the principal objective
of the EDHS project is to provide up-to-date estimates of key demographic and health
indicators, it also collects data on knowledge and attitudes of people about HIV/AIDS
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and evaluates potential exposure to the risk of HIV infection by exploring high risk
behaviors and condom use.
Sampling and Sampling Procedure
The Ethiopia Population and Housing Census (PHC) results that were conducted
by the Ethiopia Central Statistical Agency (CSA) are the sampling frames for each EDHS
implemented since 2000. A complete list of enumeration areas comprises information
about scene, type of residence (urban or rural), and estimated number of residential
households were included in the frame. When the surveys were conducted, stratified
sampling methods were used in two stages. Different sampling strata were yielded by
dividing regions in to rural and urban. Accordingly, samples of enumeration areas were
selected independently in each stratum in two stages. Meanwhile, for this study, the
sampling frames were the list of all adult population ages 15-59 years who participated in
the past three surveys and who were tested for HIV and received their test results. By
doing this, representativeness and external validity of the study were preserved.
Inclusion Criteria for the Study
For the purpose of this study, a sample of adult male and females between 15 and
59 from the three DHS databases were enrolled. The study procedure had guideline for
who can or cannot participate in the study. The inclusion criteria were age between 15
and49 years for women and 15 and 59years for men who were tested for HIV and
received HIV results.
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Sample Size Calculation and Power Analysis
A minimum power of 0.80 and alpha (significance level) of 0.05 was used to
obtain sample means in the critical region 5% of the time when the null hypothesis is
true. A power of 80 %( or 0.8) indicates that if a survey is conducted repeatedly, 8 out of
10 results will lead to statistically significant outcomes. The alpha or significance level
(0.05) is the likelihood of making a type I error or rejecting the null hypothesis when it is
true; and a probability of making a wrong decision (Faul et al., 2007; Trochim, 2006).
This study enrolled the data of 1,067 sampled people from the 2005, 2011, and
2016 EDHS (from Tigray, Amhara, Oromia, Afar, Somali, Benshangul, SNNPR,
Gambella, Harari, Dire Dawa, and Addis Ababa regions) by taking in to consideration the
total population studied by DHS, which was 26,753, and the 3% allowable error. The
people sampled in three surveys were women between the ages of 15 and 49 and men
between the ages of 15 and 59. For the 15 to 24-year-old pregnant women, data on HIV
test results from ANC clinics of public health facilities in Ethiopia have been analyzed
separately after each client record was selected using a convenience sampling method.
Data Sources
This study used multiple secondary data sources, mainly the three EDHS (2005,
2011 and 2016) databases that had sampling frames from the Population and Housing
Census conducted in 2007. The sampling frames comprise information about sites and
place of residences of people that had equal chances to be selected for the surveys. In
addition, the database of health facilities, FHAPCO, and records of HIV program
implementing partners donated mainly by United State Aid for International
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Development (USAID) and Centers for Disease Control and Prevention (CDC)Ethiopia
have been used with each organization’s consent to review the trend of HIV prevalence
and funding levels from donors.
Measurements for Variables
The EDHS survey codebook was used to detect both the dependent and
independent variables of this study. For RQ2, funding levels from donors was dependent
variable while HIV/AIDS prevalence was independent variable. Type and number of HIV
services were dependent variables while funding levels from donors were independent
variables for RQ3. For RQ4, HIV/AIDS prevalence was dependent variable while socio
economic/demographic characteristics including: age, sex, current marital status,
educational status of sampled people, employment status, number of lifetime partners,
place of living, wealth quintile, and age at first sexual intercourse were independent
variables. Likewise, to make the analysis plan and the selection of statistical tests simpler,
each variable was leveled under Nominal, Ordinal, Interval, or Ratio. As the scale of
the variable to be measured is potential to drastically affect the type of analytical
techniques that can be used on the data, and what conclusions can be drawn from the
data, all the necessary precautions were made.
Data Analysis Plan
Statistical Package for the Social Science (SPSS) Version 24 was used for
statistical analysis of data. Using it, tabulated reports have been generated, distributions
and trends have been plotted, and descriptive statistics and complex statistical analysis

46
were operated. To answer the research questions of this study, different analysis were
operated as follows:
RQ1: How has HIV prevalence changed in Ethiopia during the past 10 years?
To know if there is a statistically significant change in prevalence of HIV, a trend
analysis was made. Temporal patterns displayed by plotting yearly HIV prevalence
against year. Accordingly, exponential trend lines were fitted to prevalence data for each
regions of the country using the DHS 2005, DHS 2011, and DHS 2016 data to assess
whether there have been changes in HIV prevalence over recent years; and to assess if
these changes are statistically significant. The analysis was conducted separately for
urban and rural sites in each region whenever data are available. For each region, the
percentage change in fitted prevalence was calculated between the first and last year. The
paired sample T-Test was performed for each five year (2005 against 2011; and 2011
against 2016) as well as for the whole 10 years (2005 versus 2016) to assess whether
differences in prevalence were statistically significant at p<0.05. In addition, to forecast
how the prevalence will be changed until 2025, a time serious forecasting analysis was
done.
RQ2: How does the trend of HIV prevalence associate with funding from donors?
In order to assess the relationship or association between the HIV prevalence and
level of funding from donors’ community, perhaps there is a hypothesis that the funding
level affects the accomplishment obtained in decreasing HIV prevalence; correlational
analysis was computed to test this hypothesis. For this analysis, data on the total funding
level released for each region of the country in the past ten years and the annual
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disbursements of PEPFAR investing to HIV prevention, care, and treatment services
along with the HIV prevalence trends were correlated to identify the degree of correlation
using Pearson Correlation of Coefficient (r). In addition, the bivariate plot for the two
variables has been made to check the relationship. Once the correlation was computed,
two-tailed testing with a significance level of 0.05 was also computed to check the
significance level and to determine whether the observed correlation is a real one and not
a chance occurrence.
RQ3: What is the relationship between the type/number of services being
provided to prevent and control HIV/ADS and funding from donors?
To know if the type and number of HIV service are influenced by the funding
level from the donors’ community, the relationship between services and their number of
beneficiaries for adult treatment, adult care and support, pediatric care and support, ARV
drug, HIV testing and counseling, and Orphan and Vulnerable children served (OVC)
have been analyzed using Pearson's Chi-square test or Fisher's exact to see if there is a
statistically significant difference among them. Accordingly, the analysis exemplified if
the service types and beneficiary numbers are subjected to vary according to the level of
funding.
RQ4: What was the effect of different socioeconomic and demographic
characteristics on the trend of HIV prevalence in the past 10 years?
To know the impact of socioeconomic and demographic characteristics (age, sex,
current marital status, educational status of sampled people, employment status, number
of lifetime partners, place of living, wealth quintile, and age at first sexual intercourse,
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etc.) on the prevalence of HIV to the different segment of the population, a multiple
regression model was computed to efficiently estimate the measure of association
between the dependent variable (prevalence) and independent variables (socioeconomic
and demographic characteristics) while controlling confounding factors.
A pair wise analysis was also employed among funding level and each
explanatory variable to get the intercept, the regression coefficient for each of the
predictor variable, the t-calculated, and p-value. In addition, the full regression model
was operated to get the regression sum square (R2), and the condensed regression model
was employed to find variable with most significant p-value.
Ethical Consideration
This study used databases from formerly conducted surveys (EDHS: 2005, 2011
and 2016), Federal Ministry of Health (FMoH), and records of HIV program
implementing partners donated mainly by USAID and CDC Ethiopia. Therefore, the
issue of privacy or confidentiality was not applicable as this was already addressed by the
principal data collectors. However, to use the data from each, data use agreements were
obtained from both.
Summary
Section 2 mentioned the research design chosen to answer the research equations
and the rationale for secondary data analysis methodology. The population enrolled in
this study, and sampling and sampling procedures along with inclusion criteria were also
illustrated well. Sample size calculation and power analysis have been addressed to get
the right sample from demographic and health surveys. Last, the measurement of
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variability, data analysis plan, and ethical considerations were discussed. In Section 3,
results and findings of the study in line with the four research questions will be presented.
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Section 3: Presentation of the Results and Findings
The purpose of this quantitative study was to examine the trend of HIV
prevalence among Ethiopians and study funding levels from donors in different years for
HIV prevention, care, and treatment; and analyzing if funding shortfalls threaten the
gains made like low mortality rate due to AIDS because of the influence it may have on
HIV prevention strategies. Accordingly, I examined changes in HIV prevalence among
people who were sampled for DHS, funding levels, and type and number of services.
Section 3 includes results of statistical analyses including a paired t-test, time series
forecasting, Pearson correlation, Chi-square, Analysis of Variance (ANOVA), and
multiple linear regression (MLR) on secondary data from DHS of Ethiopia. This section
includes the results of the dependent sample t-test or paired sample t-test and time series
forecasting (RQ1), Pearson correlation coefficient (RQ2), Chi-square test (RQ3), and
multiple linear regression (MLR) (RQ4). At the end of this section, a summary statement
has been added to conclude the results.
Data Collection of Secondary Data Set
The data source of this study, Ethiopian DHS for 2005, 2011, and 2016, are
national household surveys studying nutrition, health, and population. So far, Ethiopia
has conducted four series of DHS in 2000, 2005, 2011, and 2016, and the data from the
latter three (2005, 2011, and 2016) have been considered to analyze key demographic and
health indicators over time. All the surveys were implemented by the CSA at the request
of the FMOH to back health policymakers and health program implementers in planning,
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implementing, and evaluating programs and strategies to improve the quality of life of the
population of Ethiopia.
Descriptive Demographics of the Sample
Table 1 shows descriptive analyses of the demographic characteristics of the
1,067 people sampled from the three surveys. The variables included in this analysis are
sex, age, place of residence, educational level, marital status, and region. According to
the results of this analysis, among the sampled individuals who were enrolled in the
study, males (49.5%) and females (51.5%) were almost equally represented and this was
similar in both surveys. Of the participants, 80% were between the ages of 15 and 39 for
both sexes and 78.4% were from the rural part of Ethiopia. In terms of education level,
41.8% have no education, 41.5% completed only primary school, and the remaining
16.7% have secondary school and college diplomas. In relation to marital status, 61.2%
were married and live together while 33.6% had never married. The number of widowed
and divorced participants constituted the remaining 5.2%. As the sample was designed to
represent the national population between the ages 15 to 49 years for women and ages 15
to 59 years for men, the samples were taken from each region’s urban and rural areas and
the two city administrations (Addis Ababa and Dire Dawa) proportionally in terms of the
population that each region and city had. Hence, 35% enrolled people in this study were
from Oromiya region followed by 23.9% from Amhara. The remaining were from the
other seven regions and two city administrations.
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Table 1
Selected Background Characteristics of the Sampled People from Ethiopia DHS 2005,
DHS 2011 and DHS 2016.

Year
Variable
Sex

DHS 2005

Total

%

574

53.7%

549

51.4%

Male

540

50.6%

493

46.3%

518

48.6%

15-19

1067
241

100%
22.6%

1067
244

100%
22.8%

1067
222

100%
21%

20-24

184

17.2%

181

16.9%

171

16%

25-29

158

14.8%

189

17.7%

183

17.2%

30-34

139

13%

123

11.5%

149

13.9%

35-39

123

11.5%

125

11.7%

123

11.5%

40-44

102

9.5%

82

7.7%

96

8.90%

45-49

75

7%

74

6.9%

76

7.1%

50-54

45

4.2%

49

4.5%

25

2.3%

55-59

0

0%

0

0%

22

2%

1067

100%

1067

100%

1067

100%

Rural

898

84.1%

794

74.4%

819

86.2%

Urban

169

15.9%

273

25.6%

248

13.8%

1067

100%

1067

100%

1067

100%

Secondary and
above

152

14.4%

167

15.6%

211

19.7%

Primary School

371

34.7%

462

43.2%

497

46.5%

No education

544

50.9%

438

41.2%

359

33.8%

1067

100%

1067

100%

1067

100%

Widow

50

4.6%

21

2%

0

0.0%

Divorced

29

2.7%

53

4.9%

14

1.3%

Married and
live together

630

59%

626

58.6%

704

65.9%

Never Married

358

33.8%

367

34.5%

349

32.8%

1067

100%

1067

100%

1067

100%

Total

Marital
Status

EDHS2016

49.4%

Total

Educational
Level

%

527

Total
Place of
Residence

EDHS2011

Female

Total

Sex

%

(Table continued)
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Year
Variable
Region

DHS
2005
30

%

EDHS2011

%

EDHS2016

%

2.81%

5

0.47%

8

0.75%

67

6.28%

59

5.53%

58

5.44%

9

0.84%

5

0.47%

3

0.28%

63

5.90%

4

0.37%

3

0.28%

244

22.87%

203

19.03%

221

20.71%

14

1.31%

11

1.03%

11

1.03%

38

3.56%

21

1.97%

32

3.00%

Oromiya

334

31.30%

394

36.93%

393

36.83%

Amhara

228

21.37%

278

26.05%

260

24.37%

6

0.56%

17

1.59%

8

0.75%

34

3.19%

70

6.56%

70

6.56%

1067

100%

1067

100%

1067

100%

Dire Dawa
Addis Ababa
Harari
Gambella
SNNPR
BenishangulGumuz
Somali

Afar
Tigray
Total

Study Results
RQ1
RQ1: How has HIV prevalence changed in Ethiopia during the past 10years?
Statistical assumptions. In order to observe the differences between the two sets
of values, before ART treatment officially initiated in the country (2005 prevalence) and
10 years after treatment (2016 prevalence) and assure the quality of the results, a paired
sample t-test was computed after evaluating the four main assumptions. According to
Busing (2016), the four assumptions that need to be checked to drive a paired sample ttest are that the dependent variable must be continuous, approximately normally
distributed, and contain no outliers; in addition, observations are independent of one
another. Hence, to operate this parametric procedure, all assumptions were met because
the data for prevalence were numeric and continuous and could take any value within a
range, the data were inspected for normality by using a histogram, which looked
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approximately symmetrical and bell-shaped, and in the visual assessment using a box
plot, there were no values that appear far away or outliers from the majority.
In addition to assessing the HIV prevalence changes in Ethiopia during the past
10years, by extrapolating trends and patterns among the past HIV prevalence values, time
series forecasting has been operated to predict future values or trends regarding the HIV
epidemic using the Autoregressive Integrated Moving Average (ARIMA) (0, 1, 0) model
without considering the effect of other variables. Likewise, to run the ARIMA modeling
for forecasting time series, assumptions were checked and met. According to Huck
(2004), time series analysis is based on the following assumptions: no acknowledged
/assumed predictor variables, no seasonal forms, no one time irregularities, and there are
dependable correlations between the variable to be forecast and other independent
variables.
Trend analysis and paired sample t-test results. National HIV prevalence of
Ethiopia was gradually decreasing over the 10-year study period (2005 – 2016).
However, regional trends in terms of prevalence density among all ages have varied in all
assessment periods. In 2016, the prevalence of HIV in Gambella (4.8%), Harari (2.4%),
Addis Ababa (3.4%), and Dire Dawa (4%) regions are far higher than the national
prevalence (0.9%) and the global cutoff point for generalized epidemic declarations.
Conversely, yearly HIV prevalence rates for Oromia (0.7%), Somali (0.01%),
Benishangul Gumuz (1%), and SNNPR (0.4) were less than the average annual national
HIV prevalence, as shown in Figure 1.
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Figure 2.HIV prevalence by region of Ethiopia, 2005–2016.
The observed decrement in prevalence during the 10 years intervention time in
Gambella was only about 18%. For about seven years from 2005, the prevalence was
increasing steadily, but later after 2012, it starts decline even though that prevalence is
still more than five folds higher than the national prevalence. In 2016, Gamblella was the
first region with highest HIV prevalence.
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Figure 3.The trend of national HIV prevalence of Ethiopia, 2005–2016.
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Figure 4.HIV prevalence among all age groups for Gambella region, 2005–2016.
The prevalence of HIV in SNNPR at 2016 was worse than the prevalence that the
region had ten years before 2016. In 2005, it was 0.2% while it increased to 0.9% in
2011; and gradually decreased to 0.4% in 2016. Among the 9 regions and 2 city
administrations in Ethiopia, the two regions that have higher prevalence of HIV in 2016
comparing their own prevalence data of 2005 are SNNPR and Benshangul Gumuz.
Benshangul Gumuz had prevalence of 0.5% in 2005 and 1% in 2016, which was doubled
though many prevention and control programs were run in the regions for a decade.
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Figure 5.HIV prevalence among all age groups for SNNPR, 2005–2016.
The changes in prevalence among the national urban and national rural dwellers of
Ethiopians seem following the same decreasing fashion. There is a 53 % and a 57 %
decrement of prevalence in urban and rural areas, respectively. However, at 2016, the
HIV prevalence in urban areas was seven times higher than the rural prevalence.
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Figure 6.HIV prevalence among all age groups for urban and rural dwellers, 2005–2016.
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Figure 7.HIV prevalence by age, EDHS2005, EDHS 2011, and EDHS2016.
A paired t-test was used to compare the changes in HIV prevalence rates between
the nine regions and two city administrations before and after the intervention of HIV
prevention, care and support activities. Running a paired t-test allowed to see the effect of
interventions in spite of effects unique to certain regions. Table 2 shows for the statistical
analysis output obtained from a paired sample t-test, which represents regions’ beginning
prevalence (2005) and their 2016 prevalence.
Table 2
Paired Sample T-Test among the HIV Prevalence in 2005, 2011, and 2016

Pair 1
Pair 1
Pair 1

Prevalence in 2005
to 2016
Prevalence in 2005
to 2011
Prevalence in 2011
to 2016

Mean

Paired Differences
95% Confidence
Std.
Interval of the
Std.
Error
Difference
Deviat
Mea
ion
n
Lower
Upper

.71727

.61130

.18431

.30660

1.12795

3.892

10

.10000

.65422

.19725

-.53951

.33951

-.507

10

.81727

.59083

.17814

.42035

1.21420

4.588

10

t

df

Sig.
(2tailed
)
.003
.623
.001
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The results from the outputs (Table 2) shows that the prevalence in 2005 (M =
.10, SD = .65) and the prevalence in 2016 (M = .71, SD = .61), demonstrated a significant
difference in for the general ten years national HIV prevalence (t (10) = 3.89, p = .003).
Likewise, the prevalence in the first and second five years was found to be different. In
addition, the t-value of the three analyses (3.89, -.51, and 4.59) shows the size of the
difference between the mean HIV prevalence rates of the three periods being compared.
Accordingly, the large t-value with in 2011 and 2016 indicates a correspondingly large
difference between the mean HIV prevalence rates in those years. In addition, the
analysis from the records of the 1000 pregnant women 15 to 24- Years-Old attending two
ANC clinics of public health facilities in Bishoftu and Addis Ababa from January 2006 to

Prevalence for age 15 - 49

June 2016 depicted as the HIV among pregnant women has notable decline (Figure 9).
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Figure 8.HIV prevalence by sex in 2005, 2011, and 2016.
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Figure 9.HIV among pregnant women attending ANC by year.
Time series forecasting result. In this time series analysis that was conducted for
the national, urban, and rural HIV prevalence of Ethiopia between the year 2017 and
2025, the forecasting demonstrated that there is likelihood for the HIV prevalence trend
continue decreasing beyond the year 2017 both for national, urban, and rural Ethiopia.
The HIV Prevalence will decline from 2.7% (95% CI 2.9 – 2.4%) in 2017 to 0.7% (95%
CI 1.5 – 0.0%) in 2025, 0.4% (95% CI 0.5 – 0.3%) in 2017 to 0.2% (95% CI 0.4 – 0.1%)
in 2025, and 0.9% (95% CI 1.0 – 0.7%) in 2017 to 0.5% (95% CI 1.0 – 0.1%) in 2025 for
urban, rural, and national, respectively.

61

Figure 10. Time series forecasting of national, urban, and rural HIV prevalence rates
using ARIMA model
Table 3
Forecasted HIV Prevalence Value for the Period between 2017 and 2025.
Model
Urban HIV PrevalenceModel_1
Rural HIV PrevalenceModel_2
National HIV
Prevalence-Model_3

Forecast
UCL
LCL
Forecast
UCL
LCL
Forecast
UCL
LCL

2017
2.7
2.9
2.4
.4
.5
.3
.9
1.0
.7

Forecast
2018 2019
2.4
2.2
2.7
2.6
2.1
1.8
.3
.3
.4
.5
.2
.2
.8
.8
1.0
1.1
.7
.5

2020
1.9
2.4
1.5
.3
.5
.1
.8
1.1
.5

2021
1.7
2.2
1.2
.3
.4
.1
.7
1.1
.4

2022
1.5
2.0
.9
.2
.4
.0
.7
1.1
.3

2023
1.2
1.9
.6
.2
.4
.0
.6
1.1
.2

2024
1.0
1.7
.3
.2
.4
-.1
.6
1.1
.1

2025
.7
1.5
.0
.2
.4
-.1
.5
1.0
.1

Hypothesis test result. The hypothesis being tested here is whether the HIV
prevalence in the ten years, 2005 – 2016, are the same or statistically different. In this t-
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test, the prevalence of the same regions was used to see the change in prevalence between
2005 and 2010, 2005 and 2016, and 2010 and 2016 separately. As the p-value helps to
decide whether to accept or reject the null hypothesis, it was imperative to compare the pvalues at the significance level of 0.05. The 95 percent confidence interval of the
difference provides an estimate of the boundaries between which the true mean difference
lies in 95 percent of all possible random samples of regions participating in this study.
As illustrated in Table 2, the t-statistic was obtained by dividing the mean
difference by its standard error to give the t-values of 3.89, -.51, and 4.59. The Sig. (2tailed) column for the period from 2005 to 2010 shows that the probability of obtaining a
t statistic whose absolute value is equal to or greater than the obtained t statistic is .62.
Since the significance value for the difference in HIV prevalence rates between those
years is greater than 0.05 (p =.623), it can be concluded that the average difference in
HIV prevalence rate of -.100 is due to chance variation. This means, the change in
prevalence of HIV in the first five years (2005 – 2010) was not statistically significant.
However, from 2011 to 2016, there was a gradual decrease in the HIV prevalence rate
and this change was statistical significant (t [10] = 4.59, p = .001), which led to reject the
null hypothesis.
Answers to RQ1.The results of the hypothesis tests, trend analyses and Paired

Sample T –Test, showed as the national HIV prevalence change in Ethiopia during the
past ten years was statistically significant because there was a significant difference in
scores for DHS 2005 (M = .10, SD = .65) and DHS 2016 (M = .72, SD = .61) conditions;
t (10) = 3.892, p = 0.003. However, while comparing the changes in prevalence between
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the first five years (2005 – 2011) and the second five years (2011 – 2016), the HIV
prevalence change from 2005 to 2011 was not statistically significant with t (10) = -.51, p
= .623.
RQ2

RQ2: How does the trend of HIV prevalence associate with funding from donors?
Statistical assumptions. Prior to conducting correlation analysis between the
national HIV prevalence and the annual budget, the two variables have been plotted to
visually inspect the linear relationship they have and the data follows. The bivariate plot
below (Figure 6) shows how the two variables are related or changed together without
addressing the question of causality. According to Busing FM (2016), to compute the
Pearson’s Coefficient, the data set should be normally distributed, a scatter plot should
show a linear relationship among data, no outliers, and variables should be continuous.
Accordingly, in this analysis all the assumptions were met.
The Pearson correlation result. Pearson correlation product – moment
correlations, or r, has been calculated for the national and some specific regions’ funding
level and prevalence to measure the linear relationship between the donors’ financial
support to fight HIV/AIDS and the HIV prevalence trends. Accordingly, the output
(Table 4) gives a correlation matrix for the two correlations and the correlation
coefficient show as there is a positive correlation between funding level from donors’
community for HIV prevention, care, and support, and national HIV prevalence. This
positive correlation coefficient (.635) indicates that there is a statistical significant (p =
.027) linear relationship between these two variables such that the less prevalence level
the country has nationally, the smaller the funding level from donors is. This analysis was
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also supported by the Bivariate plot (Figure 6) with regression line and R2 = 0.52, which
tells 52% of the variability in national prevalence rate of HIV is accounted for budget
level from donors like PEPFAR. However, in a separate analysis that has been computed
for all regions to see whether the allocation of funds that obtained from donors for HIV
prevention, care, and support have a similar positive correlation with their prevalence or
not, the result in two regions shows no relationship between the prevalence of HIV and
the budget obtained from donors. The Pearson Correlation and Sig. (2-tailed) for Tigray
(r = .375, p =.229), and Gambella (r = .281, p =.376). This indicates the investment to
HIV prevention, care, and treatment along with the HIV prevalence trends hasn’t been
correlated in those two regions.

Figure 11. Bivariate plot showing the relationship between the changes in the national
prevalence rate and funding level from 2005 to 2016.
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Table 4
Correlation between Funding levels from Donors and the Trend of HIV Prevalence.

National Funding Level from
Donors
National Prevalence

Correlations
National Funding
Level from
Donors
Pearson Correlation
1
Sig. (2-tailed)
N
Pearson Correlation
Sig. (2-tailed)

N
*. Correlation is significant at the 0.05 level (2-tailed).

10
.635*
.027
10

National Prevalence
.635*
.027
10
1
10

Hypothesis test result. There was a statistically significant (r (10) = .635*, p =
.027) association between the two variables; and hence, the null hypothesis stated - the
level of donors’ financial support to fight HIV/AIDS has no relationship with the
epidemiological or national HIV prevalence trends – will be now rejected and the
alternative hypothesis accepted.

13%

1%

2%
6%
52.20%
25.80%

US Government

Global fund

Non-profit international foundations

Other external donors

Public Revenue

Private sectors

Figure 12.Sources of funds for HIV/AIDS (2005 - 2016).
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Answers to RQ2. As correlation measures the linear relationship between two
variables, the correlation coefficient between HIV prevalence and funding levels from
donors’ community has a value of .635* (Table 4) indicates that the association between
the two variables is statistically significant (p = .027) and have a positive linear
relationship such that the less prevalence the country has, the smaller that country’s
funding level from donors community is.
RQ3
RQ3: What is the relationship between the type and number of services or
responses to prevent and control HIV/ADS and funding from donors?
Statistical assumptions. This research question was analyzed by using crosstabs
and Pearson’s chi-square. The assumptions to apply a chi-square test include (a) datasets
are large enough, (b) not be used on correlated data/ independence, (c) nominal or ordinal
categories, and (d) more than 80% of the contingency cells having expected values
greater than five (Busing, Weaver, &Dubois , 2015), have been checked for all and
confirmed for meeting the assumptions.
The Chi-square test result. The frequency cross tabulated result (Table 5)
indicates that there is a highly significant relationship between the different HIV
prevention, care, and support services and funding level. The sample included the
information of 1067 people served in different years, 37.7% who were served for adult
treatment, 64.7% who were provided adult care and support, 12.3% who obtained
pediatric care and support, 37.5% who were put on ARV drugs, and 59.4% who were
counseled and tested for HIV. The budget allotted for different service areas was also
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different in different years (Figure 7 and 8). Accordingly, the Pearson Chi-Square Values
for all service areas indicate as there is a highly significant relationship between: funding
level and adult treatment, χ2 (2, N = 1067) = 1425.7, p< .001, funding level and adult
care and support, χ2 (2, N = 1067) = 268.7, p< .001, funding level and pediatrics care and
support, χ2 (2, N = 1067) = 12.5, p = .002, funding level and ARV drug, χ2 (2, N = 1067)
= 38.5, p< .001, and funding level and HIV testing and counseling, χ2 (2, N = 1067) =
181.2, p< .001.
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Table 5
Type and Number of HIV Services and Funding Levels for 2005, 2011, and 2016.
Funding Level for each year
50,000,001100,000,000
NO

Adult
Treatment

YES

Total

No

Adult Care
and
Support

Yes

Total

NO

Pediatric
Care and
Support

YES

Total

NO

ARV
Drugs

YES

Total

NO
HIV
Testing
and
Counseling

YES

Total

Count

100,000,001 150,000,000

Total

250,000,001300,000,000

1067

224

702

1993

% within Funding
Level for each year
Count
% within Funding
Level for each year
Count
% within Funding
Level for each year

100.00%

21.00%

65.80%

62.3%

0
0.00%

843
79.00%

365
34.20%

1208
37.7%

1067
100.00%

1067
100.00%

1067
100.00%

3201
100%

Count
% within Funding
Level for each year
Count
% within Funding
Level for each year
Count
% within Funding
Level for each year
Count
% within Funding
Level for each year
Count

577
54.08%

225
21.09%

328
30.74%

1130
35.3%

490
45.92%

842
78.91%

739
69.26%

2071
64.7%

1067
100.00%

1067
100.00%

1067
100.00%

3201
100%

946
88.66%

906
84.91%

957
89.69%

2809
87.7%

% within Funding
Level for each year
Count
% within Funding
Level for each year
Count
% within Funding
Level for each year
Count
% within Funding
Level for each year
Count
% within Funding
Level for each year
Count
% within Funding
Level for each year
Count
% within Funding
Level for each year
Count
% within Funding
Level for each year

121

161

110

392

11.34%

15.09%

10.31%

12.2%

1067
100.00%

1067
100.00%

1067
100.00%

3201
100%

607
56.89%

651
61.01%

743
69.63%

2001
62.5%

460
43.11%

416
38.99%

324
30.37%

1200
37.4%

1067
100.00%

1067
100.00%

1067
100.00%

3201
100%

267
25.02%

567
53.14%

467
43.77%

1301
40.6%

800
74.98%

500
46.86%

600
56.23%

1900
59.4%

1067
100.00%

1067
100.00%

1067
100.00%

3201
100%

Pearson
ChiSquare
Value
1425.776a

df

Asymptotic
Significance
(2-sided

0

0.000

268.795a

2

0.000

12.564a

2

0.002

38.521a

2

0.000

181.294a

2

0.000

Hypothesis test results. As there was a statistically significant (p < 0.05)
association between the number and type of HIV related services and funding level, null
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hypotheses, which states the type and number of services being provided to prevent and
control HIV/ADS in Ethiopia have no relationship with the yearly funding levels from
the donor community, will be rejected secondary to comparing the p-value, which is less
than the significance level (0.05). In addition, the population proportions in each category
are not consistent with the specified values in each category; and hence, the observed
values of samples in relation to service areas given in different years with different
funding levels and expected values from the specified distribution are statistically
different.
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Figure 13. The budget amount allotted for different service areas in different years.
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Figure 14. The proportion of budget utilized in different service areas from 2005 – 2016
Answers to RQ3.Results of the hypothesis tests using a chi-square test of
independence showed a significant associations and meaningful effect of funding level on
each of the dependent selected variable. The large chi-square statistics and small
significant level (P< .005) for each indicates that it is very unlikely that these variables
are independent of each other. Hence, funding level matters who gets what services and
the frequency.
RQ4
RQ4: What was the effect of different socioeconomic and demographic
characteristics on the trend of HIV prevalence in the past 10years?
Statistical assumptions. To carry out this multiple regression, all the required
assumptions have been checked to make sure that the data used could actually be
analyzed using multiple regression. Some of the assumptions checked were whether the
dependent variable is measurable in a continuous scale, if there are two or more
independent variables, if there are no significant outliers, and if there is a linear
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relationship between the outcome variable and the independent, which was checked by
using a scatter plot. As most of the multiple regression assumptions were met, this
investigation has been computed to see the variables that are good predictors of the
current HIV status.
The regression test result. To investigate the effect of predictor variables, age at
first sexual intercourse, place of living, number of lifetime partners, educational status,
current marital status, sex, employment (in the last 12 months), wealth quintile, and age
at the time of study, on an outcome variable – HIV Positive Status, a multiple linear
regression, an extension of a linear regression, was computed using SPSS statistics.
Consequently, a significant regression equation was found (F (9, 1056) = 12.639, p <
.001) with an R2 of = .375. The R, R-Square (R2), adjusted R2, and the standard error of
the estimate were used to determine how well the regression model fit the data. Hence,
the R – value (the "R" Column of Table 6) is .612, which represents the multiple
correlation coefficient between the predictors and the dependent variable and indicating a
good degree of association with fair quality of prediction. The R2 value (the "R Square"
column of Table 6) is .375; and this represents the coefficient of determination that is the
proportion of variance in the dependent variable, HIV prevalence, can be explained by
the independent variable. This means, according to this analysis the dependent variables
explained 37.5% of the variability of the dependent variable, HIV status, which of course
not too much.
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Table 6
Model Summary Table for Predictors

Model
1

R
.612a

Model Summary
Adjusted R
R Square
Square
.375
.590

Std. Error of the
Estimate
4.112

Table 7
F-ratio in the ANOVA Table

Regression
Residual

Sum of Squares
1.438
13.351

ANOVAa
df
9
1056

Total

14.789

1065

Model
1

Mean Square
.160
.013

F
12.639

Sig.
.000b

a. Dependent Variable: HIV Status
b. Predictors: (Constant), Age at first sexual intercourse, PLACE OF LIVING, Number of lifetime partners, Educational
Status of sampled People , Current marital status, Sex of Sampled people, Employment (last 12 months), Wealth quintile,
Age of sampled people

Table 8
Information about the Effect of Individual Predictor Values

Model
1(Constant)
Age of sampled people
Sex of Sampled people
Current marital status
Educational Status of sampled
People
Employment (last 12 months)
Number of lifetime partners
PLACE OF LIVING
Wealth quintile
Age at first sexual intercourse
a. Dependent Variable: HIV Status

Coefficientsa
Unstandardized Standardized
Coefficients Coefficients
Std.
B Error
Beta
-.012
.027
-.005
.009
-.038
.007
.011
.029
.065
.009
.344

t
-.443
-.586
.613
6.966

Sig.
.658
.558
.540
.000

95.0% Confidence
Interval for B
Lower
Upper
Bound
Bound
-.064
.041
-.022
.012
-.015
.029
.047
.084

.009

.006

.067

1.511

.131

-.003

.021

.038
.015
-.087
5.886E-5
-.018

.013
.006
.011
.005
.007

.148
.087
-.348
.001
-.186

2.951
2.534
-7.765
.012
-2.626

.003
.011
.000
.991
.009

.013
.003
-.109
-.010
-.032

.063
.026
-.065
.010
-.005
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Table 8 provided the necessary information to predict HIV status from
socioeconomic and demographic characteristics, as well as determine whether HIV status
contributes statistically significantly to the model by looking at the Sig. column. The
unstandardized coefficients indicates as the value of dependent variable or the likelihood
of getting HIV increases based on the increase in each unit changes in predictor value of
current marital status, employment (last 12 months), number of lifetime partners, place of
living, and age at first sexual intercourse. Meanwhile, the Beta coefficient for current
marital status (whether never married, or married and living together, or divorced, or
widowed) is found to be the better predictor for the current HIV status (β = .344, p <
.001). The significant test for each of the independent variables in the model was also
indicated under p-value. The p-value for the variables: current marital status (p = .047),
employment in the last 12 months (p = .013), number of lifetime partners (p = .003),
place of living (p < .001), and age at first sexual intercourse (p = .009) indicate strong
evidence against the null hypothesis. In addition, the coefficient for current marital status
is .344. So, for every unit increase in marital status, a 0.34 unit increase in prevalence is
predicted, holding all the variables constant. Likewise, for every unit increase in number
of lifetime partners, a .087 unit increase in prevalence is also predicted.
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Figure 15.HIV prevalence by wealth quintile.
Hypothesis test result. The F-ratio in the ANOVA (Table 7) shows the overall
variance accounted for in the model and the overall regression model fit to the data and
some of the independent variables statistically significantly predict the dependent
variable, (F (9, 1056) = 12.639, p< .001), indicating the null hypothesis, that states The
HIV prevalence, in the past ten years, show similar trends to all Socioeconomic and
Demographic Characteristics is rejected. The remaining variables, age (p = .558), sex (p
= .540), educational status (p = .131), and wealth or economic status (p =.991) were not
statistically significantly to the predictors.
Answers to RQ4.As per the multiple linear regression model summary and overall

fit statistics, the adjusted R² of the model is .590 with the R² = .375. This means that the
linear regression indicated 5 of the 9 predictors explain 37.5% of the variance, which
shows how well the regression equation fits the data to predict the dependent variable
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significantly. Hence, the prevalence of HIV was not the same for all socioeconomic and
demographic characteristics in the past 10years, 2005 – 2016.
Summary
Section 3 illustrated major findings of the four research questions of this study. In
this section, the purpose of using quantitative study, the data sources, the result of
descriptive analyses to the demographic characteristics of sampled people, statistical
assumptions for each statistical tests, test results, and answers to research questions have
included. This doctoral study examined the data collected for the three (2005, 2011, and
2016) Demographic and Health Surveys conducted in Ethiopia. The target populations
for these surveys were all women ages 15 to 49 years and all men ages 15 to 59 years.
The result of this study has demonstrated as the national HIV prevalence changed
in the country during the past ten years was statistically significant because there was a
difference in scores for prevalence in 2005 (M = .65, SD = .61) and the prevalence in
2016 (M = .71, SD = .61) conditions; (t (10) = 3.89, p = .003). The national trend of HIV
prevalence was also found associated with funding levels from donors’ community, r =
.635, p .027, and funding level matters who gets what service areas, P< .005. Last, the
result depicted as the prevalence of HIV in the study periods was not the same for all
socioeconomic and demographic characteristics, F (9, 1056) = 12.639, p = .00001.
In the next chapter, chapter 4, the detail interpretation and analysis will be
presented along with its application to Professional Practice and Implications for Social
Change. Likewise, section 4 will encompass comparison of findings to literature,
limitations, recommendation, and conclusions that are pertinent to this doctoral study.
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Section 4: Application to Professional Practice and Implications for Social Change
The purpose of this quantitative secondary data analysis was to examine the
trends of HIV prevalence in Ethiopia from 2005 to 2016 and funding levels from donors
for HIV prevention, care, and support services during those years. In addition, the study
explored if funding from donors is a proximate determinant for prevalence change,
funding shortfalls threaten the gains like reduction of mortality rate due to HIV/AIDS,
and there is an association between declining funding levels and the change in prevalence
of HIV/AIDS. The reasons for conducting this study were to understand how HIV
prevalence is being changed in Ethiopia, how the change in HIV prevalence is associated
with funding levels from donors, how the change in funding level influence the type and
number of services, and the effect of different socioeconomic and demographic
characteristics on the trend of HIV prevalence.
This study illustrated that the national HIV prevalence change in Ethiopia during
the time from 2005 to 2016 was statistically significant (t (10) = 3.892, p = 0.003).HIV
prevalence and funding levels from donors have a linear relationship (r (10) = .635, p =
.027), and there are significant associations and a meaningful effect of funding level on
number and type of services (P< .005), and the regression test computed to investigate
the effect of predictor variables showed that current marital status, employment
status(last 12 months), number of lifetime partners, place of living, and age of first
instance of sexual intercourse are better predictors for current HIV status (β = .344, p<
.001).
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Interpretation of the Findings
My analyses of the DHS and facility-based data to answer the four research
questions indicated significant relationships between the trend of HIV prevalence,
funding level, and the number and type of services. In the following subsection, I
compared findings to the literatures and the proximate determinant framework. The
comparison follows the research questions’ series.
Comparison of Prevalence Findings with Literature
National prevalence. According to Tadele, Abebaw, and Abdulsemed(2016),
even though there were 160,000 new HIV infections annually in Ethiopia, this number
gradually declined by 81% in 2016. The number of newly infected people has also
declined by 0.1352 per 1000 people since 1990 and reached 0.33 per 1000 among all ages
in 2016. Kendall and Danel (2014) said that the burden of HIV in Ethiopia shows a
decreasing trend because of the substantial advances that have been made to increase
access to services, reduce stigma and discrimination, increase social support, and
mobilize communities. Likewise, the findings of this study confirm that HIV prevalence
in Ethiopia declined from 1.4% in 2005 to 0.9% in 2016 for all groups and this change
was valid in a statistical sense. However, between 2006 and2011, the prevalence was
unchanged despite many prevention and control measures were undertaken.
Regional prevalence. UNAIDS (2013) showed Ethiopia has a generalized and
heterogeneous type of epidemic with regional variations. EDHS (2011) had also
illustrated variations in HIV prevalence among regions ranges from 0.9%, 1%, 5.2%, to
6.5% for SNNPR, Oromiya, Addis Ababa, and Gambella regions, respectively. This
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variation was also observed in this analysis. Gambella had the highest prevalence in the
past 10years (6% in 2005, 6.5% in 2011, and 4.8% in2016) followed by Addis Ababa
(4.7% in2005, 5.2% in2011, and 3.4 % in2016). There were also some regions that had
lower HIV prevalence before ten years and in 2016 their HIV prevalence increased
noticeably. Regions with the lowest prevalence at the beginning and increased later
include SNNPR (0.2% in 2005 and 0.4% in 2016) and Benshangul Gumuz (0.5% in 2005
and 1% in 2016).
HIV Prevalence by Urban and Rural Areas of Ethiopia. Ethiopia had a
prevalence reduction of 55%in between 2000 to 2008, p<0.00. However, at the beginning
of 2005, the difference between urban and rural HIV prevalence had a large width
ranging from 0.7% for rural areas to 5.7% for urban areas, but this variation reached
0.6% in 2011 and 0.4% in 2016 for rural areas and 4.2% in 2011 and 2.9% in 2016 for
urban areas. In this study, 78.4% of sampled people enrolled were from rural parts of
Ethiopia while 21.6% were from urban areas. The reduction in prevalence in the
mentioned period was also observed in many African countries by 25% both in urban and
rural areas, which was a statistically significant change. While Ethiopia had a prevalence
reduction of 55% during 2000 to 2008, Kenya had a reduction of60% in rural and urban
areas (p<0.01). Likewise, studies show that HIV prevalence had exhibited a dropping
trend in greater than 80% of African countries both in urban and rural areas.
Prevalence by sex and age group. In many countries, there is evidence
indicating that HIV prevalence among young people is declining due to changes in risky
sexual behavior including early sexual debut, multiple sexual partners, and unprotected
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sexual intercourse. The largest decrease (42%) has been observed in African American
women since 2005; and in the time from 2011 to 2016, in US, there was a 25% decline in
prevalence while the prevalence for men has declined by 11% since 2005 (CDC, 2016).
Similarly, the decreasing prevalence trend has also been observed in Ethiopia both for
women and men between the ages of 15 and 49. In the period between 2005 and2016,
prevalence declined for women (statistically significant at p<0.05) and was higher for
men (1.9% versus 0.9% in 2005, 1.9% versus 1.0% in 2011, and 1.9% versus 0.6% in
2016). As age of women increases, HIV prevalence also increased from 0.4% to 3% for
the 15-19 and 40-44 age groups, respectively. The increase in men for 15-19 age group
was 0.1%, and for the 40-49 age groups, it increased by 1.6%. Meanwhile, even though
the HIV prevalence trend for men age 15-49 declined, the change was not statistically
significant for the period between 2005 and2011.
HIV prevalence in the future. Hailay, Paul, Kifle, and Lillian (2017) showed the
likelihood of increasing or relapsing of HIV prevalence in Ethiopia after 2016 because of
high ART defaulters’ rates (22.3%); however, the time series analysis result of this study
shows, unless unforeseen internal and external factors affect the trend, the HIV
prevalence will continue to downfall from 2.7% in 2017 to 0.7% in 2025 for urban, from
0.4% in 2017 to 0.2% in 2025 for rural, and from 0.9% in 2017 to 0.5% in 2025 for the
country, Ethiopia. The justification given by Hailay, Paul, Kifle, and Lillian for the
likelihood of increasing of HIV prevalence to the future was linked to the decreased trend
of adhering to ART. According to this study, one out of five Ethiopian dropped from
taking ART and those who withdraw from the treatment (usually women and
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HIV/tuberculosis co-infected people) are more likely to contribute for further
transmission of HIV.
Comparison of Funding Level Findings with Literature
Ethiopia spends 3 to 5% of their GDP on health, which makes annual per capita
health spending less than $25, while foreign funding covers 30 to 50%. In 2012, the total
money spent for HIV/AIDS in Ethiopia was $ 405 million, of which $350 million (86%)
was obtained from external sources, $55 million (13%) from public income, and
$680,000 (0.2%) from the private sector (WHO, 2013). Though health spending in
Ethiopia had similar trends for many years, since 2008, funding from external donors is
flat lining or decreasing (Vassall et al., 2013).The reasons for declining funding levels
were decreases in both bilateral and multilateral funding, which accounts for a 50% drop
of funding levels, exchange rate variations, which accounts for a20% drop of funding
levels, and U.S. contributions to the Global Fund to Fight AIDS, Malaria, and
Tuberculosis, due to the law that limits its funding to one-third of total contributions to
the Global Fund (Jen & Adam, 2017). Therefore, one of the objectives of this study was
to know if this funding decrement is correlated with HIV infection rates or prevalence
trends. Accordingly, the results of this analysis showed that there is a positive correlation
between funding from donors in terms of HIV prevention, care, and support, and national
HIV prevalence. The positive correlation coefficient (.635) indicates that there is a
statistically significant (p = .027) linear relationship between these two variables such
that the lower HIV prevalence level the country has nationally, the smaller the funding
level from donors is. An empirical research finding that was conducted by Azuine et al.
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(2014) on the impact of international humanitarian assistance on combating HIV/AIDS
had also showed that the decrease of donor assistance in developing countries followed
an overall reduction of HIV infection rates.
According to the finding of this study, while the prevalence of HIV decreased
from 1.4% to 1.1% between the years 2011 to 2016, the PEPFAR fund was decreased by
57%. Though this decrement follows the descent of prevalence, it doesn’t seem
proportional and may cause shortage of fund to carryover started programs appropriately.
As Samji (2013) illustrated that defunding the HIV/AIDS program disproportionately
may cause catastrophic phenomenon like flaring up the disease again as HIV drugs are
not curing AIDS and should be taken life-long. This was also supported by UNAIDS
(2017) because ending HIV/AIDS depend largely on the funding level and ability to
provide HIV treatment to all who need it. In the meantime, nowadays, Ethiopia adopted
the global 90–90-90 HIV prevention targets by 2020 which is part of strategies designed
to eliminate HIV/AIDS epidemics by 2030; and to attain these targets funding level will
remain to be a critical area.
Last, according to MoH (2014), the proportion of spending HIV budget by
regions shows that 43% was expended by federal/central government, 13% in Amhara,
13% Addis Ababa, 11% Oromia, 8% South Regions, and 22% for the remaining seven
regions or towns and this distribution considers the prevalence and total population in
each region. This spending proportion was in concurrence with the finding of this
analysis except the deviation observed in two regions, Gambella and Tigraye. The
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investment to HIV prevention, care, and treatment along with the HIV prevalence trends
hasn’t been correlated in those two regions, r = .375, p =.229.
Comparison of Findings Regarding Service Areas and Funding
According to FHAPCO (2012), the expenditure of money from all external
sources disperse as 30.9% for HIV treatment, 19.5% for prevention, 29.7% for national
system strengthening and program coordination, and 6.8% for OVC support. This
distribution of funds was also similar to the finding of this analysis for the remaining
years. The two main external sources of fund for HIV prevention, care, and treatment are
PEFPAR and Global Fund. While 31% of PEPFAR’s support goes to national systems
strengthening and program management, 27% and 17% go to treatment and care, and
prevention, respectively. On the other hand, 51% Global Fund share goes primarily to
treatment; and the remaining 28% and 9% go to systems strengthening and program
management and prevention, respectively. In relation to the finding of this study, the type
and number of HIV service in the study period were influenced by the funding level from
the donors’ community. The number of people served for different service areas were
varied with the total funding level, but proportional. Adjusting the number and type of
services with the level of funding could be applicable for some services; however, it will
not be always applicable as some service areas are sensitive. For instance, while this
analysis is done, there are 460,564 people on ART and they need to get their treatment
for their life time unless cure is possible in the future. This activity, unlike other
activities, can’t be discontinued because funding level is decreasing. Therefore, even
though there is a statistically significant (p < 0.05) association between the number and
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type of HIV related services and funding level, some activities like ART need to get due
attention. In general, to know whether the funding breakdown by thematic area is a costeffective way of investment or not, further studies shall be considered in the future.
HIV Prevalence by Socio-demographic Characteristics
One of the aims of this analysis was to determine the important factors that fuel
the HIV prevalence among variable that were used in the three EDHSs. Therefore, the
effect of different Socioeconomic and Demographic Characteristics on trend of HIV
prevalence in the past ten years was analyzed using a multiple regression. The analyses
discovered that the odds of HIV infection were generally elevated among widowed and
divorced women. When the current marital status of sampled people assessed, 77% and
93% widowed were women in EDHS2005 and EDHS 2011, respectively. The number of
divorced women was also found high in both surveys. Among the divorced sampled
people, 91% were women in EDHS 2005, 77% in EDHS 2011, and 83% in DHS2016,
which has a good degree of association with fair quality of prediction or the likelihood of
getting HIV increases based on the current marital status. This finding was confirmed
with a number of studies. A study conducted by (Rand & Daniel, 2004) in Kampala and
Lusaka on HIV within behavioral risk groups identified a significant rate of infection
among divorced and widowed women followed by singles. This was also consistent with
another study conducted by (Mmbaga et al., 2007) in Arusha, Tanzania, revealed that the
HIV prevalence is higher in divorced and separated individuals compared to cohabiting
and married couples. Another analysis from 13 sub-Saharan Africa countries also has
discovered that separated and widowed individuals are at higher risk of acquiring HIV
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than single or married, especially if they are females. For example in Cote d’ivoire13%
versus 6%, Kenya 17% versus 8%, Lesotho 46% versus 26%, Ethiopia 6% versus 1%,
Rwanda 12% versus 2%, and Zimbabwe 46% versus 17% the prevalence of HIV was
higher in divorced and remarried women than others (de Walque & Kline,2012).
Age at first sexual intercourse was also one of the important variables found to
have strong association with HIV prevalence. Accordingly, this study has recognized a
significant rate of infection among women with early sexual debut. For both sexes who
first had sex after the age of 20, the HIV prevalence was low. However, women who first
had sexual intercourse at the age 18 or below had a prevalence of 1.9% while men who
reported first sexual intercourse at age 16 had a prevalence of 1.4%. Similar studies have
discovered that higher level of infection among girls than boys of same age because of a
number of facts. According to Hallett et al. (2007), during young age, girls usually make
sex with older men while boys have sex with girls having relatively similar ages. Poverty
usually motivates many girls to have sexual intercourse with older men or ‘sugar daddies’
and 90 percent of HIV infections contributed by 15 – 24 years old women (Jewkes,
1999). For both sexes, HIV prevalence increases with increases number of sexual
partners. The prevalence of HIV among women increases from 0.8% to 7% while the
number of lifetime sexual partners increase from one to 10 or more. However, this level
of exposure is lower for men, and hence, it grows from 0.3% to 2.9% with 10 or more
lifetime sexual partners. This finding was also confirmed by another study conducted by
Hallett et al. (2007) that shows how age at first sex is associated with HIV infection.
According to this study that was conducted in Zimbabwe, women who started sex at the

85
earlier age are more likely to be infected by HIV as they will have many lifetime sexual
partners than those who stayed abstain from sex in their teenage.
Place of living or place of residence was also identified as a potential factor
affecting the prevalence of the epidemic because of the socio-economic and sociocultural variation in between rural and urban areas. Among sampled people for this study,
34% were from the urban areas. In the meantime, the finding depicted that people living
in urban areas are at higher risk of acquiring the disease than rural dwellers. In rural areas
as there is high influence of traditional values and limited sexual network, the prevalence
is low. Therefore, in urban areas, HIV prevalence is seven times higher (2.9% versus
0.4%) than in rural areas for both sexes. While we see separately for women and men,
urban HIV prevalence for women is 3.6% and the rural prevalence is 0.6% while the
matching percentages for men are 2.0% and 0.2%, correspondingly.
In many study findings, educational status mentioned as one of the important
socio-economic factors affecting the AIDS epidemic all over the world. Accordingly, in
this study even though the impact of education on prevalence of HIV was not found
statistically significant (p =.132), the result showed that people who completed primary
school are at higher risk of getting the disease than illiterate or no education. As it is
believed, education improves the awareness of individuals to access different information
about the epidemic and get services in addition to improving personal income in the long
run. According to Fylkesness et al. (1998), getting HIV infection is growing significantly
with increasing educational status or accomplishment in rural and urban inhabitants of
Zambia. Another study done in Zimbabwe had also showed that educated persons have
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higher risk getting HIV infection in Africa because of the fact that people have possibility
of changing sexual partners frequently (Mmbaga et al., 2007).
Another socio-economic factor that was assessed for its effect on prevalence of
HIV epidemic was wealth quintile. Like the educational attainment, despite the fact that
wealth of individuals was not a statistically significant determinant factor for HIV
prevalence in this study finding (p = .991), there is a trend showing that people in the
highest wealth quintile have a higher HIV prevalence. For instance, among women
sampled in EDHS 2016 and with highest wealth quintile, the HIV prevalence was 3.0%
while women in lower wealth quintiles (poor) had 1.0% prevalence. Nevertheless, the
discriminatory attitudes and knowledge of prevention methods were increased with
increased wealth quintile for both women and men. Other studies have also showed the
impact of poverty in limiting media exposure, cause for migration of people, lessen
access to health education and nutrition, and increase sexual exploitation (Casale &
Whiteside, 2006). Meanwhile, the available study findings on the relationship between
poverty and HIV/AIDS are inconsistent. Casale and Whiteside (2006) showed that HIV
infection doesn’t disproportionately affect the poorer in sub-Saharan Africa; and people
in the wealthiest quintile have a higher HIV prevalence than those in the lower wealth
quintiles (poorer quintiles). According to Mmbaga et al. (2007), this finding was
supported by stating that wealthier people tend to have higher HIV prevalence than
poorer people. To the reverse, a study done by Bloom et al. (2002) revealed that poverty
is a key factor for HIV transmission because it increases people exposure to the virus.
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Findings in the Context of the Theoretical Framework
I applied the proximate determinant framework to examine the association of
proximate variables, like funding level for Anti-HIV/AIDS activities, socio-demographic
characteristic, and service areas to learn if these have a direct effect on the outcome
variable and influence the change of it. Accordingly, the five most important proximate
determinants for men and women were current marital status, employment (last 12
months), number of lifetime partners, place of Living, and age at first sexual intercourse,
which are potential to change or affect or interfere and have immediate effects on the
outcome, HIV prevalence. In addition, the linear relationships between the donors’
financial support and prevalence have been measured.
Based on the guiding principles of the proximate determinants conceptual
framework, the marital status found to be one of the variables that affect the HIV
prevalence. Women and men reported ever having been married had higher probability of
acquiring HIV than those who have never married. Meanwhile, the highest HIV
prevalence noticed among the widowed and divorced people. According to this
conceptual framework, married people have higher risk level than unmarried; and hence,
while the HIV prevalence for never married women and men in 2005 and 2011 were
0.7% and 0.2%, respectively; divorced and widowed were positive by 8.1% and 5.6%,
respectively, in 2005; and 5.9% and 14.5%, respectively, in 2011. This shows that
married are six times more likely (OR = 6.51 95% CI = 3.49–5.44%), and widowed are
twenty times more likely (OR = 19.94, 95% CI = 16.04–24.79%) than unmarried to
acquire HIV.
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HIV prevalence also differs remarkably by employment status. The risk of
unemployed for the epidemic is lower than employed people because of a number of
reasons including movement to other places for work and income, which is highly
correlated with wealth. Wealthy individuals usually have wider social and sexual network
and are at higher risk of getting the infection. The conceptual framework has also showed
as the number of lifetime sexual partners has a huge impact to raise the likelihood to be
infected in both sexes though the risk is much higher for females. This was illustrated in
both the three EDHS findings. While the prevalence of HIV in people with one lifetime
sexual partner is less than 1 percent, it may go up to the level of 7 percent for those who
have multiple lifetime sexual partners. In addition, this theoretical framework has
highlighted the prevalence difference in place of living. In the rural community where the
overwhelming majority of Ethiopians are living, the prevalence of HIV has been noted
very low in the study periods because of the strong traditional values and less sexual
networking. According to EDHS (2011), the urban areas in Ethiopia are seven times
more affected with the prevalence than rural areas.
Limitations of the Study
This study was based on data that were collected in the previous three
Demographic and Health Surveys (DHS) of Ethiopia. Those surveys, like any other DHS,
were nationally-representative household surveys and contain a wide range of indicators
about health, nutrition, and population. Accordingly, generalizability was not an issue.
However, to provide estimates for small regions, DHS samples were not large enough
and, in some extent, it was affecting the generalizability; otherwise, the findings and
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conclusions from DHS were generalizable and trustworthy. Getting the actual spending
amount for HIV related services had limitation because some partners’ accounting
information systems do not contain specific budgetary and expenditure lines and
comprehensive expenditure records. Because of this, under-estimation or overestimation
was not ruled out. In addition, all predictors of HIV: demographic – ethnicity, country by
birth, and sexuality; behavioral – condom use, unsafe sex, alcohol use, substance use,
male sex with male, and multiple sexual partners; clinical – weight loss, fever and chills,
cough, diarrhea, respiratory tract infection, oncology, and hematology were not included
as they were not in EDHS data; and hence, internal validity, estimate truth about
inferences concerning causal relationship, could be affected. The other limitation for
working with survey datasets was that datasets are compressed .ZIP files contains
multiple working files along with data definition files but getting the instruction file to
work with ZIP files was challenging.
Recommendations
There are several recommendations that might advance findings in progressing
the curve of HIV prevalence, enhancing financial sustainability, targeting effective
responses, and work on specific and to the right predictors. First, although there is an
advancement in relation to HIV prevalence in the country, which remains to be
categorized by a low-intensity, mixed epidemic with significant heterogeneity, it is
meaningfully differ in between geographical areas (6.6% in Gambella, 5.0% in Addis
Ababa, and 0.7% in Southern Nations, Nationalities and Peoples’ (SNNPR) region.
Therefore, it is advisable to sort out and categorize regions as per their HIV burden and
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prioritize them to address the greatest unmet needs first. In those geographic areas with
greatest unmet needs or high prevalence, community and facility-based testing services
and HIV Self-Testing shall be strengthened, access to treatment services shall be
improved to accelerate ART linkage and the Test and Start, and make stronger the active
disclosure support and targeted demand creation for testing. Second, to have constant and
expanded funding mechanisms in place to fund the AIDS responses, there should be a
thought of alternative sources of public revenue and domestic investment to transition
from donor support to a sustainable domestic response; collaboration with all donors,
civil society organizations and private sectors; and finding innovative ways of funding
the responses by self. More countries have been stated for considering innovative
financing mechanisms to raised resources for HIV like Zimbabwe, a 3% tax on all
formally employed individuals; Rwanda and Uganda taxes on mobile phone usage;
Congo, Madagascar, Mali, Mauritius, and Niger from an airline tax (African Union,
2013). Third, in order to address the problem related to funding level decrement, vigorous
financial tracking system should be in place to understand the funding trends and its
relationship with type or number of responses to prevent and control HIV/ADS. Knowing
the type or number of services that are critical and effective will enable to use the scarce
resource appropriately and bring the desired impact shortly. Meanwhile, since this study
had some limitation to get adequate service related data, I propose to conduct a mixed
method research to identify which service is more contributing to end the epidemic.
Fourth, findings of this study recommend to give due attention for following segment of
population with highest HIV transmission: widowed and divorced men and women,

91
unemployed men and women, people who have less than three life time sexual partners,
children who practiced their first sexual intercourse before the age 16, urban inhabitants,
and people with highest wealth quintile. However, as stated on the limitation of this study
section, as many other important predictors of HIV were not in EDHS data, I suggest the
need for further investigation to know the drivers of the epidemic in a better way.
Implications for Professional Practice and Social Change
Professional Practice
This section provides recommendations to professional practice and positive
social change implications relevant to knowing the association between HIV prevalence
and funding level and identifying the socio-economic and demographic factors that fuel
the epidemic. I am managing this study to be a good examiner and provide clues on how
to ensure the HIV response is sustainable. If the response becomes sustainable, it empowers to
have an enabled environment, appropriate services, conducive system, and resources essential to
effectively and efficiently control the HIV epidemic. Accordingly, in the following subsections, I
am describing methodological, theoretical, and empirical implications to professional

practice.
Methodology. This analysis could be improved by using mixed method research.
The secondary data can still provide a supporting role in the study, but to assess the
socio-economic and demographic factors that driving the epidemic, both qualitative and
quantitative design could give a better result to answer the research questions. According
to Creswell and Plano Clark (2007), mixed method is more than merely gathering and
examining both types of data; likewise, it includes the use of both methods in the process
so that the general strength of a study is better than either of the two designs.
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Theory. In this study, I attempted to combine demographic, behavioral and

epidemiological approaches to develop a conceptual framework for the study of the main
factors determining the HIV epidemic in the population. However, this framework
initially has been used comprehensively in the study of fertility and child survival to
measure the association between biological, personal, cultural, environmental, and
behavioral factors and their influence on human fertility (Boerma & Weir, 2005).
Accordingly, while this framework was used in this study, the objective was to recognize
a set of variables, called “proximate determinants,” that can be influenced by changes in
circumstantial variables or by interventions that have a direct effect on the outcomes; and
to tease-out factors affecting HIV vulnerability. Thus, even though extensive literature
review has been made on the application of the framework, fine-tuning and modifying
this framework may be needed to make it pertinent to capture the predominant situation
in the particular study area and to quantify these situations within the variables at each
stage of the framework.
Empiricism. I propose that the empirical implication for this trend analysis may help
to promote the way how HIV prevalence and funding levels are correlated and affect the

scope of the response. Information obtained through trend analysis would tell what was
happening in the past, being going on now, and forecasting future patterns of the healthrelated issues, which in turn is significant in fine-tuning public health policy and
interventions (Rothman, 1998). In addition, systematically reviewing the effect of
predictor variables will use to be more selective in the process of implementation and to be
focused on the target while investing on HIV with limited resource as i nternational

assistance from donors is either declined or remained flat. A systematic review is
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indispensable to perceive lifestyle, clinical, demographic, and laboratory characteristics
of patients which might be connected with HIV infection in primary care; and
analytically assess and understand available evidences to act with the right measure
(Norman &Griffiths, 2014).
Positive Social Change
The findings support Walden’s mission by providing recommendations to
professional practice and positive social change implications relevant to knowing the
association between HIV prevalence and funding level and identifying the socio-economic
and demographic factors that fuel the epidemic. The aim is to examine the trend of HIV

prevalence and funding levels and analyzing those data if the funding shortfalls are
subjected to threaten the gains made on HIV prevention strategies in the future. This
study suggests at the individual and family level that cognitive, social, and technical
competencies and skills associated with safer sex and drug use practices need to be
improved and be supportive for HIV preventive practices. At the organizational level,
there is a need to critically analyze and synthesize HIV/AIDS studies to establish critical
issues and indicators that may explain the driving forces of the epidemic and trends, and
inform the healthcare decision-makers with findings of the four research questions so that
they will place more value on such works in their deliberations and in their interactions
with stakeholders for sustainable financing initiatives. At societal or policy level, it will
help to bring changes in the system of implementation; and find the best solutions to HIV
epidemic control and prevention strategies, which is the most burdensome health
problems, by meet the long-term needs of people living with the problem.
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Conclusion
The objective of this study was to examine the trend of HIV prevalence and
funding levels from donors’ and analyzing how these variables are correlated and
affected the scope of the response. Accordingly, the results were important because it
illustrated the trends in HIV prevalence over time and concluded: a) even though the
trend in changing prevalence in the first and second five years was found to be different;
in general, the national HIV prevalence was declining significantly over the ten-year
study period, b) there was a regional variation in prevalence density among all ages, c)
the association between HIV prevalence and funding levels from donors is statistically
significant and have a positive linear relationship, c) a significant associations and
meaningful effect of funding on who gets what services, on what frequency, and how
responses are highly depend on the amount of fund available, and d) the prevalence of
HIV was not the same for all socioeconomic and demographic characteristics and
presented population subgroups that are with higher risk of HIV-infection. However, as
the source of data for this study was DHS, the limitations of using secondary data could
apply here and definitive conclusions about the relationships between HIV prevalence
and funding level cannot be made via correlation analysis alone. Therefore, additional
national rigorous analysis are needed to comprehend the associations between
programmatic efforts, funding level, reported behavioral change, and changes in
prevalence of HIV.
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